• No results found

Trine Naalsund AndreassenPharmacokinetic, pharmacodynamicand pharmacogenetic aspects ofoxycodone treatment in cancer pain

N/A
N/A
Protected

Academic year: 2022

Share "Trine Naalsund AndreassenPharmacokinetic, pharmacodynamicand pharmacogenetic aspects ofoxycodone treatment in cancer pain"

Copied!
161
0
0

Laster.... (Se fulltekst nå)

Fulltekst

(1)

Doctoral theses at NTNU, 2011:167

Trine Naalsund Andreassen

Pharmacokinetic, pharmacodynamic and pharmacogenetic aspects of

oxycodone treatment in cancer pain

ISBN 978-82-471-2880-0 (printed ver.) ISBN 978-82-471-2881-7 (electronic ver.) ISSN 1503-8181

NTNU Norwegian University of Science and Technology Thesis for the degree of philosophiae doctor Faculty of Medicine Department of Circulation and Medical Imaging

Trine Naalsund Andreassen Doctoral theses at NTNU, 2011:167

(2)

Ig^cZCVVahjcY6cYgZVhhZc

E]VgbVXd`^cZi^X!

e]VgbVXdYncVb^XVcY

e]VgbVXd\ZcZi^XVheZXih d[dmnXdYdcZigZVibZci^c XVcXZgeV^c

I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg IgdcY]Z^b!?jcZ'%&&

CdglZ\^VcJc^kZgh^ind[

HX^ZcXZVcYIZX]cdad\n

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

E]VgbVXd`^cZi^X!

e]VgbVXdYncVb^XVcY

e]VgbVXd\ZcZi^XVheZXih d[dmnXdYdcZigZVibZci^c XVcXZgeV^c

I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg IgdcY]Z^b!?jcZ'%&&

CdglZ\^VcJc^kZgh^ind[

HX^ZcXZVcYIZX]cdad\n

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

E]VgbVXd`^cZi^X!

e]VgbVXdYncVb^XVcY

e]VgbVXd\ZcZi^XVheZXih d[dmnXdYdcZigZVibZci^c XVcXZgeV^c

I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg IgdcY]Z^b!?jcZ'%&&

CdglZ\^VcJc^kZgh^ind[

HX^ZcXZVcYIZX]cdad\n

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

E]VgbVXd`^cZi^X!

e]VgbVXdYncVb^XVcY

e]VgbVXd\ZcZi^XVheZXih d[dmnXdYdcZigZVibZci^c XVcXZgeV^c

I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg IgdcY]Z^b!?jcZ'%&&

CdglZ\^VcJc^kZgh^ind[

HX^ZcXZVcYIZX]cdad\n

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

(3)

NTNU

CdglZ\^VcJc^kZgh^ind[HX^ZcXZVcYIZX]cdad\n I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

>H7C.,-"-'"),&"'--%"%eg^ciZYkZg#

>H7C.,-"-'"),&"'--&",ZaZXigdc^XkZg#

>HHC&*%("-&-&

9dXidgVaI]ZhZhViCICJ!'%&&/&+, Eg^ciZYWnIVe^gJiign``

NTNU

CdglZ\^VcJc^kZgh^ind[HX^ZcXZVcYIZX]cdad\n I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

>H7C.,-"-'"),&"'--%"%eg^ciZYkZg#

>H7C.,-"-'"),&"'--&",ZaZXigdc^XkZg#

>HHC&*%("-&-&

9dXidgVaI]ZhZhViCICJ!'%&&/&+, Eg^ciZYWnIVe^gJiign``

NTNU

CdglZ\^VcJc^kZgh^ind[HX^ZcXZVcYIZX]cdad\n I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

>H7C.,-"-'"),&"'--%"%eg^ciZYkZg#

>H7C.,-"-'"),&"'--&",ZaZXigdc^XkZg#

>HHC&*%("-&-&

9dXidgVaI]ZhZhViCICJ!'%&&/&+,

NTNU

CdglZ\^VcJc^kZgh^ind[HX^ZcXZVcYIZX]cdad\n I]Zh^h[dgi]ZYZ\gZZd[e]^adhde]^VZYdXidg

;VXjaind[BZY^X^cZ

9ZeVgibZcid[8^gXjaVi^dcVcYBZY^XVa>bV\^c\

Ig^cZCVVahjcY6cYgZVhhZc

>H7C.,-"-'"),&"'--%"%eg^ciZYkZg#

>H7C.,-"-'"),&"'--&",ZaZXigdc^XkZg#

>HHC&*%("-&-&

9dXidgVaI]ZhZhViCICJ!'%&&/&+,

(4)

Farmakokinetiske,farmakodynamiskeogfarmakogenetiske aspektervedoksykodonibehandlingavkreftsmerter

”‘‹•‡ •‡”–‡” ˜‡† ”‡ˆ–•›†‘ ‡” ‡– —–ˆ‘”†”‡†‡ ’”‘„އǤ ‡Ž˜ ‘ •–‡”‡

•‡”–‡Ž‹†”‡†‡ ‡†‹ƒ‡–‡” •‘ ‘”ˆ‹ ‡ŽŽ‡” ‘•›‘†‘ ȋ‘’‹‘‹†‡”Ȍ ‡” ‹ —–•–”ƒ–

„”—ǡ ‡” †‡– ƒ‰‡ ”‡ˆ–’ƒ•‹‡–‡” •‘ ‹‡ ‘’’¤” –‹Ž•–”‡‡Ž‹‰ •‡”–‡Ž‹†‹‰ ‡ŽŽ‡”

’Žƒ‰‡• ƒ˜ „‹˜‹”‹‰‡”Ǥ  ‰”— –‹Ž ƒ– ƒ ‹‡ ˆ¤” ‰‘† ‘ ˜‹”‹‰ Š‘• ƒŽŽ‡ǡ ‡” ƒ–

‘’‹‘‹†‡” ˜‹”‡” •˜§”– ˆ‘”•Œ‡ŽŽ‹‰ ˆ”ƒ ‹†‹˜‹† –‹Ž ‹†‹˜‹†Ǥ ‘” ¤ —‡ „‡†”‡

•‡”–‡„‡Šƒ†Ž‹‰‡ ƒ˜ ”‡ˆ–’ƒ•‹‡–‡” ‡” †‡– ˜‹–‹‰ ¤ ˆ‹‡ —– ‡” ‘ Š˜‘”ˆ‘” †‡– ‡”

•Ž‹‡ˆ‘”•Œ‡ŽŽ‡”Ǥ

‡‡ •–—†‹‡ ‡” ‡ †‡Ž ƒ˜ ‡– Ǧ’”‘•Œ‡– •‘ Šƒ” ‹Ž—†‡”– ʹʹͻͶ ”‡ˆ–’ƒ•‹‡–‡”Ǥ ˜

†‹••‡˜ƒ”†‡–Ͷ͸ͳ•‘„‡›––‡–‘’‹‘‹†‡–‘•›‘†‘‘–•‹‡”‡ˆ–•‡”–‡”Ǥ‡–‡”Ž‹–‡

—•ƒ’‘Š˜‹Ž‡ˆƒ–‘”‡”•‘’¤˜‹”‡”˜‹”‹‰‡ƒ˜‘•›‘†‘Š‘•”‡ˆ–’ƒ•‹‡–‡”Ǥ

¤Ž‡–‡††‡‡•–—†‹‡˜ƒ”†‡”ˆ‘”¤—†‡”•ލ‡‘ƒŽ‹‡Ž‹‰‡Ž‹‹•‡‘’’Ž›•‹‰‡”

•ƒ‡ ‡† ¤Ž‹‰‡” ƒ˜ •‡”— ‘•‡–”ƒ•Œ‘‡” ƒ˜ ‘•›‘†‘ ‘‰

‡†„”›–‹‰•’”‘†—–‡” ȋ‡–ƒ„‘Ž‹––‡”Ȍ ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‰‡‡” ˆ‘”

‡†„”›–‹‰•‡œ›‡”ǡƒˆ‘”Žƒ”‡ˆ‘”•Œ‡ŽŽ‡”‡ŽŽ‘‹†‹˜‹†‡”ǤŽ‹‹•‡‘’’Ž›•‹‰‡”

•‘ „އ ‹Ž—†‡”–ǡ ˜ƒ” ’ƒ•‹‡–‡• ƒŽ†‡”ǡ ŒÞǡ ”‘’’•ƒ••‡‹†‡• ȋȌǡ †ƒ‰Ž‹‰

‘•›‘†‘ †‘•‡ǡ ‘’’Ž›•‹‰‡” ‘ –‹ŽŽ‡‰‰•‡†‹ƒ‡–‡”ǡ Š˜‘” އ‰‡ ’ƒ•‹‡–‡‡ Šƒ”

„”—– ‘’‹‘‹†‡”ǡ Š˜‘” ƒ‰‡ –‹‡” •‹†‡ ˆ‘””‹‰‡ †‘•‡ǡ ˆ›•‹• ˆ—•Œ‘••–ƒ–—•ǡ •ƒ–

‹†‹ƒ–‘”‡”ˆ‘”އ˜‡”Ǧ‘‰›”‡ˆ—•Œ‘Ǥ

•›‘†‘ „”›–‡• ‡† ‹ އ˜‡”‡ Š‘˜‡†•ƒ‡Ž‹‰ ƒ˜ ͵Ͷ ‘‰ ʹ͸ ‡œ›‡”Ǥ ‹••‡

‡œ›‡‡•ƒ–‹˜‹–‡–ƒ„Ž‹’¤˜‹”‡–ƒ˜ƒ†”‡‡†‹ƒ‡–‡”’ƒ•‹‡–‡„”—‡”Ǥ–‹ŽŽ‡‰‰

‡•‹•–‡”‡” †‡– ˆŽ‡”‡ ˜ƒ”‹ƒ–‡” ƒ˜ CYP2D6Ǧ‰‡‡– •‘ ’¤˜‹”‡” †ƒ‡Ž•‡ ƒ˜ †‡–

•‡”–‡•–‹ŽŽ‡†‡ ‡†„”›–‹‰•’”‘†—–‡– ‘•›‘”ˆ‘Ǥ ‹ŽŽ‡‰‰•‡†‹ƒ‡–‡” ‘‰

‰‡˜ƒ”‹ƒ–‡”ƒ˜CYP2D6ƒ†‡”ˆ‘”˜§”‡‡†¤„‡•–‡‡†‡‡‡Ž–‡’ƒ•‹‡–•‹––‹˜¤

ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡”‹„Ž‘†‡–ǡ‘‰†‡”‡†ƒ•Œ‡†‡Þ†˜‡†‹‰‡†‘•‡”‹‰‡

ƒ˜‘•›‘†‘Ǥ

–—†‹‡ Šƒ” ˜‹•– ƒ– †ƒ‰Ž‹‰‡ †‘•‡ ‘•›‘†‘ ˜ƒ” †‡ ˆƒ–‘”‡ •‘ ˆ‘”Žƒ”–‡ †‡

‘„•‡”˜‡”–‡ ˜ƒ”‹ƒ•Œ‘‡ ‹ „Ž‘†‹˜¤‡– „‡•–ǡ ‡• ŒÞ ‘‰ „”— ƒ˜ ‡†‹ƒ‡–‡” •‘

’¤˜‹”‡”‡†„”›–‹‰‡ƒ˜‘•›‘†‘˜‹ƒ͵Ͷ‡œ›‡‡ǡ‰ƒ˜†‡•–Þ”•–‡‡ˆˆ‡–‡’¤

Farmakokinetiske,farmakodynamiskeogfarmakogenetiske aspektervedoksykodonibehandlingavkreftsmerter

”‘‹•‡ •‡”–‡” ˜‡† ”‡ˆ–•›†‘ ‡” ‡– —–ˆ‘”†”‡†‡ ’”‘„އǤ ‡Ž˜ ‘ •–‡”‡

•‡”–‡Ž‹†”‡†‡ ‡†‹ƒ‡–‡” •‘ ‘”ˆ‹ ‡ŽŽ‡” ‘•›‘†‘ ȋ‘’‹‘‹†‡”Ȍ ‡” ‹ —–•–”ƒ–

„”—ǡ ‡” †‡– ƒ‰‡ ”‡ˆ–’ƒ•‹‡–‡” •‘ ‹‡ ‘’’¤” –‹Ž•–”‡‡Ž‹‰ •‡”–‡Ž‹†‹‰ ‡ŽŽ‡”

’Žƒ‰‡• ƒ˜ „‹˜‹”‹‰‡”Ǥ  ‰”— –‹Ž ƒ– ƒ ‹‡ ˆ¤” ‰‘† ‘ ˜‹”‹‰ Š‘• ƒŽŽ‡ǡ ‡” ƒ–

‘’‹‘‹†‡” ˜‹”‡” •˜§”– ˆ‘”•Œ‡ŽŽ‹‰ ˆ”ƒ ‹†‹˜‹† –‹Ž ‹†‹˜‹†Ǥ ‘” ¤ —‡ „‡†”‡

•‡”–‡„‡Šƒ†Ž‹‰‡ ƒ˜ ”‡ˆ–’ƒ•‹‡–‡” ‡” †‡– ˜‹–‹‰ ¤ ˆ‹‡ —– ‡” ‘ Š˜‘”ˆ‘” †‡– ‡”

•Ž‹‡ˆ‘”•Œ‡ŽŽ‡”Ǥ

‡‡ •–—†‹‡ ‡” ‡ †‡Ž ƒ˜ ‡– Ǧ’”‘•Œ‡– •‘ Šƒ” ‹Ž—†‡”– ʹʹͻͶ ”‡ˆ–’ƒ•‹‡–‡”Ǥ ˜

†‹••‡˜ƒ”†‡–Ͷ͸ͳ•‘„‡›––‡–‘’‹‘‹†‡–‘•›‘†‘‘–•‹‡”‡ˆ–•‡”–‡”Ǥ‡–‡”Ž‹–‡

—•ƒ’‘Š˜‹Ž‡ˆƒ–‘”‡”•‘’¤˜‹”‡”˜‹”‹‰‡ƒ˜‘•›‘†‘Š‘•”‡ˆ–’ƒ•‹‡–‡”Ǥ

¤Ž‡–‡††‡‡•–—†‹‡˜ƒ”†‡”ˆ‘”¤—†‡”•ލ‡‘ƒŽ‹‡Ž‹‰‡Ž‹‹•‡‘’’Ž›•‹‰‡”

•ƒ‡ ‡† ¤Ž‹‰‡” ƒ˜ •‡”— ‘•‡–”ƒ•Œ‘‡” ƒ˜ ‘•›‘†‘ ‘‰

‡†„”›–‹‰•’”‘†—–‡” ȋ‡–ƒ„‘Ž‹––‡”Ȍ ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‰‡‡” ˆ‘”

‡†„”›–‹‰•‡œ›‡”ǡƒˆ‘”Žƒ”‡ˆ‘”•Œ‡ŽŽ‡”‡ŽŽ‘‹†‹˜‹†‡”ǤŽ‹‹•‡‘’’Ž›•‹‰‡”

•‘ „އ ‹Ž—†‡”–ǡ ˜ƒ” ’ƒ•‹‡–‡• ƒŽ†‡”ǡ ŒÞǡ ”‘’’•ƒ••‡‹†‡• ȋȌǡ †ƒ‰Ž‹‰

‘•›‘†‘ †‘•‡ǡ ‘’’Ž›•‹‰‡” ‘ –‹ŽŽ‡‰‰•‡†‹ƒ‡–‡”ǡ Š˜‘” އ‰‡ ’ƒ•‹‡–‡‡ Šƒ”

„”—– ‘’‹‘‹†‡”ǡ Š˜‘” ƒ‰‡ –‹‡” •‹†‡ ˆ‘””‹‰‡ †‘•‡ǡ ˆ›•‹• ˆ—•Œ‘••–ƒ–—•ǡ •ƒ–

‹†‹ƒ–‘”‡”ˆ‘”އ˜‡”Ǧ‘‰›”‡ˆ—•Œ‘Ǥ

•›‘†‘ „”›–‡• ‡† ‹ އ˜‡”‡ Š‘˜‡†•ƒ‡Ž‹‰ ƒ˜ ͵Ͷ ‘‰ ʹ͸ ‡œ›‡”Ǥ ‹••‡

‡œ›‡‡•ƒ–‹˜‹–‡–ƒ„Ž‹’¤˜‹”‡–ƒ˜ƒ†”‡‡†‹ƒ‡–‡”’ƒ•‹‡–‡„”—‡”Ǥ–‹ŽŽ‡‰‰

‡•‹•–‡”‡” †‡– ˆŽ‡”‡ ˜ƒ”‹ƒ–‡” ƒ˜ CYP2D6Ǧ‰‡‡– •‘ ’¤˜‹”‡” †ƒ‡Ž•‡ ƒ˜ †‡–

•‡”–‡•–‹ŽŽ‡†‡ ‡†„”›–‹‰•’”‘†—–‡– ‘•›‘”ˆ‘Ǥ ‹ŽŽ‡‰‰•‡†‹ƒ‡–‡” ‘‰

‰‡˜ƒ”‹ƒ–‡”ƒ˜CYP2D6ƒ†‡”ˆ‘”˜§”‡‡†¤„‡•–‡‡†‡‡‡Ž–‡’ƒ•‹‡–•‹––‹˜¤

ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡”‹„Ž‘†‡–ǡ‘‰†‡”‡†ƒ•Œ‡†‡Þ†˜‡†‹‰‡†‘•‡”‹‰‡

ƒ˜‘•›‘†‘Ǥ

–—†‹‡ Šƒ” ˜‹•– ƒ– †ƒ‰Ž‹‰‡ †‘•‡ ‘•›‘†‘ ˜ƒ” †‡ ˆƒ–‘”‡ •‘ ˆ‘”Žƒ”–‡ †‡

‘„•‡”˜‡”–‡ ˜ƒ”‹ƒ•Œ‘‡ ‹ „Ž‘†‹˜¤‡– „‡•–ǡ ‡• ŒÞ ‘‰ „”— ƒ˜ ‡†‹ƒ‡–‡” •‘

’¤˜‹”‡”‡†„”›–‹‰‡ƒ˜‘•›‘†‘˜‹ƒ͵Ͷ‡œ›‡‡ǡ‰ƒ˜†‡•–Þ”•–‡‡ˆˆ‡–‡’¤

Farmakokinetiske,farmakodynamiskeogfarmakogenetiske aspektervedoksykodonibehandlingavkreftsmerter

”‘‹•‡ •‡”–‡” ˜‡† ”‡ˆ–•›†‘ ‡” ‡– —–ˆ‘”†”‡†‡ ’”‘„އǤ ‡Ž˜ ‘ •–‡”‡

•‡”–‡Ž‹†”‡†‡ ‡†‹ƒ‡–‡” •‘ ‘”ˆ‹ ‡ŽŽ‡” ‘•›‘†‘ ȋ‘’‹‘‹†‡”Ȍ ‡” ‹ —–•–”ƒ–

„”—ǡ ‡” †‡– ƒ‰‡ ”‡ˆ–’ƒ•‹‡–‡” •‘ ‹‡ ‘’’¤” –‹Ž•–”‡‡Ž‹‰ •‡”–‡Ž‹†‹‰ ‡ŽŽ‡”

’Žƒ‰‡• ƒ˜ „‹˜‹”‹‰‡”Ǥ  ‰”— –‹Ž ƒ– ƒ ‹‡ ˆ¤” ‰‘† ‘ ˜‹”‹‰ Š‘• ƒŽŽ‡ǡ ‡” ƒ–

‘’‹‘‹†‡” ˜‹”‡” •˜§”– ˆ‘”•Œ‡ŽŽ‹‰ ˆ”ƒ ‹†‹˜‹† –‹Ž ‹†‹˜‹†Ǥ ‘” ¤ —‡ „‡†”‡

•‡”–‡„‡Šƒ†Ž‹‰‡ ƒ˜ ”‡ˆ–’ƒ•‹‡–‡” ‡” †‡– ˜‹–‹‰ ¤ ˆ‹‡ —– ‡” ‘ Š˜‘”ˆ‘” †‡– ‡”

•Ž‹‡ˆ‘”•Œ‡ŽŽ‡”Ǥ

‡‡ •–—†‹‡ ‡” ‡ †‡Ž ƒ˜ ‡– Ǧ’”‘•Œ‡– •‘ Šƒ” ‹Ž—†‡”– ʹʹͻͶ ”‡ˆ–’ƒ•‹‡–‡”Ǥ ˜

†‹••‡˜ƒ”†‡–Ͷ͸ͳ•‘„‡›––‡–‘’‹‘‹†‡–‘•›‘†‘‘–•‹‡”‡ˆ–•‡”–‡”Ǥ‡–‡”Ž‹–‡

—•ƒ’‘Š˜‹Ž‡ˆƒ–‘”‡”•‘’¤˜‹”‡”˜‹”‹‰‡ƒ˜‘•›‘†‘Š‘•”‡ˆ–’ƒ•‹‡–‡”Ǥ

¤Ž‡–‡††‡‡•–—†‹‡˜ƒ”†‡”ˆ‘”¤—†‡”•ލ‡‘ƒŽ‹‡Ž‹‰‡Ž‹‹•‡‘’’Ž›•‹‰‡”

•ƒ‡ ‡† ¤Ž‹‰‡” ƒ˜ •‡”— ‘•‡–”ƒ•Œ‘‡” ƒ˜ ‘•›‘†‘ ‘‰

‡†„”›–‹‰•’”‘†—–‡” ȋ‡–ƒ„‘Ž‹––‡”Ȍ ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‰‡‡” ˆ‘”

‡†„”›–‹‰•‡œ›‡”ǡƒˆ‘”Žƒ”‡ˆ‘”•Œ‡ŽŽ‡”‡ŽŽ‘‹†‹˜‹†‡”ǤŽ‹‹•‡‘’’Ž›•‹‰‡”

•‘ „އ ‹Ž—†‡”–ǡ ˜ƒ” ’ƒ•‹‡–‡• ƒŽ†‡”ǡ ŒÞǡ ”‘’’•ƒ••‡‹†‡• ȋȌǡ †ƒ‰Ž‹‰

‘•›‘†‘ †‘•‡ǡ ‘’’Ž›•‹‰‡” ‘ –‹ŽŽ‡‰‰•‡†‹ƒ‡–‡”ǡ Š˜‘” އ‰‡ ’ƒ•‹‡–‡‡ Šƒ”

„”—– ‘’‹‘‹†‡”ǡ Š˜‘” ƒ‰‡ –‹‡” •‹†‡ ˆ‘””‹‰‡ †‘•‡ǡ ˆ›•‹• ˆ—•Œ‘••–ƒ–—•ǡ •ƒ–

‹†‹ƒ–‘”‡”ˆ‘”އ˜‡”Ǧ‘‰›”‡ˆ—•Œ‘Ǥ

•›‘†‘ „”›–‡• ‡† ‹ އ˜‡”‡ Š‘˜‡†•ƒ‡Ž‹‰ ƒ˜ ͵Ͷ ‘‰ ʹ͸ ‡œ›‡”Ǥ ‹••‡

‡œ›‡‡•ƒ–‹˜‹–‡–ƒ„Ž‹’¤˜‹”‡–ƒ˜ƒ†”‡‡†‹ƒ‡–‡”’ƒ•‹‡–‡„”—‡”Ǥ–‹ŽŽ‡‰‰

‡•‹•–‡”‡” †‡– ˆŽ‡”‡ ˜ƒ”‹ƒ–‡” ƒ˜ CYP2D6Ǧ‰‡‡– •‘ ’¤˜‹”‡” †ƒ‡Ž•‡ ƒ˜ †‡–

•‡”–‡•–‹ŽŽ‡†‡ ‡†„”›–‹‰•’”‘†—–‡– ‘•›‘”ˆ‘Ǥ ‹ŽŽ‡‰‰•‡†‹ƒ‡–‡” ‘‰

‰‡˜ƒ”‹ƒ–‡”ƒ˜CYP2D6ƒ†‡”ˆ‘”˜§”‡‡†¤„‡•–‡‡†‡‡‡Ž–‡’ƒ•‹‡–•‹––‹˜¤

ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡”‹„Ž‘†‡–ǡ‘‰†‡”‡†ƒ•Œ‡†‡Þ†˜‡†‹‰‡†‘•‡”‹‰‡

ƒ˜‘•›‘†‘Ǥ

–—†‹‡ Šƒ” ˜‹•– ƒ– †ƒ‰Ž‹‰‡ †‘•‡ ‘•›‘†‘ ˜ƒ” †‡ ˆƒ–‘”‡ •‘ ˆ‘”Žƒ”–‡ †‡

‘„•‡”˜‡”–‡ ˜ƒ”‹ƒ•Œ‘‡ ‹ „Ž‘†‹˜¤‡– „‡•–ǡ ‡• ŒÞ ‘‰ „”— ƒ˜ ‡†‹ƒ‡–‡” •‘

’¤˜‹”‡”‡†„”›–‹‰‡ƒ˜‘•›‘†‘˜‹ƒ͵Ͷ‡œ›‡‡ǡ‰ƒ˜†‡•–Þ”•–‡‡ˆˆ‡–‡’¤

Farmakokinetiske,farmakodynamiskeogfarmakogenetiske aspektervedoksykodonibehandlingavkreftsmerter

”‘‹•‡ •‡”–‡” ˜‡† ”‡ˆ–•›†‘ ‡” ‡– —–ˆ‘”†”‡†‡ ’”‘„އǤ ‡Ž˜ ‘ •–‡”‡

•‡”–‡Ž‹†”‡†‡ ‡†‹ƒ‡–‡” •‘ ‘”ˆ‹ ‡ŽŽ‡” ‘•›‘†‘ ȋ‘’‹‘‹†‡”Ȍ ‡” ‹ —–•–”ƒ–

„”—ǡ ‡” †‡– ƒ‰‡ ”‡ˆ–’ƒ•‹‡–‡” •‘ ‹‡ ‘’’¤” –‹Ž•–”‡‡Ž‹‰ •‡”–‡Ž‹†‹‰ ‡ŽŽ‡”

’Žƒ‰‡• ƒ˜ „‹˜‹”‹‰‡”Ǥ  ‰”— –‹Ž ƒ– ƒ ‹‡ ˆ¤” ‰‘† ‘ ˜‹”‹‰ Š‘• ƒŽŽ‡ǡ ‡” ƒ–

‘’‹‘‹†‡” ˜‹”‡” •˜§”– ˆ‘”•Œ‡ŽŽ‹‰ ˆ”ƒ ‹†‹˜‹† –‹Ž ‹†‹˜‹†Ǥ ‘” ¤ —‡ „‡†”‡

•‡”–‡„‡Šƒ†Ž‹‰‡ ƒ˜ ”‡ˆ–’ƒ•‹‡–‡” ‡” †‡– ˜‹–‹‰ ¤ ˆ‹‡ —– ‡” ‘ Š˜‘”ˆ‘” †‡– ‡”

•Ž‹‡ˆ‘”•Œ‡ŽŽ‡”Ǥ

‡‡ •–—†‹‡ ‡” ‡ †‡Ž ƒ˜ ‡– Ǧ’”‘•Œ‡– •‘ Šƒ” ‹Ž—†‡”– ʹʹͻͶ ”‡ˆ–’ƒ•‹‡–‡”Ǥ ˜

†‹••‡˜ƒ”†‡–Ͷ͸ͳ•‘„‡›––‡–‘’‹‘‹†‡–‘•›‘†‘‘–•‹‡”‡ˆ–•‡”–‡”Ǥ‡–‡”Ž‹–‡

—•ƒ’‘Š˜‹Ž‡ˆƒ–‘”‡”•‘’¤˜‹”‡”˜‹”‹‰‡ƒ˜‘•›‘†‘Š‘•”‡ˆ–’ƒ•‹‡–‡”Ǥ

¤Ž‡–‡††‡‡•–—†‹‡˜ƒ”†‡”ˆ‘”¤—†‡”•ލ‡‘ƒŽ‹‡Ž‹‰‡Ž‹‹•‡‘’’Ž›•‹‰‡”

•ƒ‡ ‡† ¤Ž‹‰‡” ƒ˜ •‡”— ‘•‡–”ƒ•Œ‘‡” ƒ˜ ‘•›‘†‘ ‘‰

‡†„”›–‹‰•’”‘†—–‡” ȋ‡–ƒ„‘Ž‹––‡”Ȍ ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‰‡‡” ˆ‘”

‡†„”›–‹‰•‡œ›‡”ǡƒˆ‘”Žƒ”‡ˆ‘”•Œ‡ŽŽ‡”‡ŽŽ‘‹†‹˜‹†‡”ǤŽ‹‹•‡‘’’Ž›•‹‰‡”

•‘ „އ ‹Ž—†‡”–ǡ ˜ƒ” ’ƒ•‹‡–‡• ƒŽ†‡”ǡ ŒÞǡ ”‘’’•ƒ••‡‹†‡• ȋȌǡ †ƒ‰Ž‹‰

‘•›‘†‘ †‘•‡ǡ ‘’’Ž›•‹‰‡” ‘ –‹ŽŽ‡‰‰•‡†‹ƒ‡–‡”ǡ Š˜‘” އ‰‡ ’ƒ•‹‡–‡‡ Šƒ”

„”—– ‘’‹‘‹†‡”ǡ Š˜‘” ƒ‰‡ –‹‡” •‹†‡ ˆ‘””‹‰‡ †‘•‡ǡ ˆ›•‹• ˆ—•Œ‘••–ƒ–—•ǡ •ƒ–

‹†‹ƒ–‘”‡”ˆ‘”އ˜‡”Ǧ‘‰›”‡ˆ—•Œ‘Ǥ

•›‘†‘ „”›–‡• ‡† ‹ އ˜‡”‡ Š‘˜‡†•ƒ‡Ž‹‰ ƒ˜ ͵Ͷ ‘‰ ʹ͸ ‡œ›‡”Ǥ ‹••‡

‡œ›‡‡•ƒ–‹˜‹–‡–ƒ„Ž‹’¤˜‹”‡–ƒ˜ƒ†”‡‡†‹ƒ‡–‡”’ƒ•‹‡–‡„”—‡”Ǥ–‹ŽŽ‡‰‰

‡•‹•–‡”‡” †‡– ˆŽ‡”‡ ˜ƒ”‹ƒ–‡” ƒ˜ CYP2D6Ǧ‰‡‡– •‘ ’¤˜‹”‡” †ƒ‡Ž•‡ ƒ˜ †‡–

•‡”–‡•–‹ŽŽ‡†‡ ‡†„”›–‹‰•’”‘†—–‡– ‘•›‘”ˆ‘Ǥ ‹ŽŽ‡‰‰•‡†‹ƒ‡–‡” ‘‰

‰‡˜ƒ”‹ƒ–‡”ƒ˜CYP2D6ƒ†‡”ˆ‘”˜§”‡‡†¤„‡•–‡‡†‡‡‡Ž–‡’ƒ•‹‡–•‹––‹˜¤

ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡”‹„Ž‘†‡–ǡ‘‰†‡”‡†ƒ•Œ‡†‡Þ†˜‡†‹‰‡†‘•‡”‹‰‡

ƒ˜‘•›‘†‘Ǥ

–—†‹‡ Šƒ” ˜‹•– ƒ– †ƒ‰Ž‹‰‡ †‘•‡ ‘•›‘†‘ ˜ƒ” †‡ ˆƒ–‘”‡ •‘ ˆ‘”Žƒ”–‡ †‡

‘„•‡”˜‡”–‡ ˜ƒ”‹ƒ•Œ‘‡ ‹ „Ž‘†‹˜¤‡– „‡•–ǡ ‡• ŒÞ ‘‰ „”— ƒ˜ ‡†‹ƒ‡–‡” •‘

’¤˜‹”‡”‡†„”›–‹‰‡ƒ˜‘•›‘†‘˜‹ƒ͵Ͷ‡œ›‡‡ǡ‰ƒ˜†‡•–Þ”•–‡‡ˆˆ‡–‡’¤

(5)

‹˜¤‡–ƒ˜‘•›‘†‘‹„Ž‘†‡–‘‰ˆ‘”Бކ‡–‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘Ǥ”—ƒ˜‡†‹ƒ‡–‡”

•‘Š‡‡”ʹ͸‡œ›‡‡Šƒ††‡‹‰‡„‡–›†‹‰ˆ‘”‹˜¤‡–ƒ˜‘•›‘†‘‡ŽŽ‡”

‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘ˆ‘”Бކ‡–‹„Ž‘†‡–Ǥ

‡– ˜ƒ” ‹‰‡ •ƒ‡Š‡‰ ‡ŽŽ‘ ‹˜¤‡– ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‡–ƒ„‘Ž‹––‡‡

‘”‘•›‘†‘‘‰‘”‘•›‘”ˆ‘‹„Ž‘†‡–‘‰•‡”–‡‹–‡•‹–‡–ǡ‘‰„‹˜‹”‹‰‡”ȋ˜ƒŽ‡ǡ

–”Þ––Ї– ‘‰ ‘‰‹–‹˜ ˆ—•Œ‘ȌǤ ‹‡˜‡Ž ˜ƒ” „”— ƒ˜ ͵Ͷ Ї‡”‡ ˆŽ—‘ƒœ‘Ž

ƒ••‘•‹‡”–‡†‹†”‡•‡”–‡ǡ‡•ލ–‡‰†‡ƒ˜‡–ƒ„‘Ž‹––‡‘•›‘”ˆ‘’ƒ”†‘•ƒŽ–

‘ ˜ƒ” ƒ••‘•‹‡”– ‡† ‡ ލ‹‰ ‹ •‡”–‡ ‹ †‡‡ ‰”—’’‡ ƒ˜ ’ƒ•‹‡–‡”Ǥ ‡––‡ ‡”

˜ƒ•‡Ž‹‰ ¤ ˆ‘”Žƒ”‡ǡ ‡ ˜‹ ‘„•‡”˜‡”–‡ ‘‰•¤ ƒ– ’ƒ•‹‡–‡” •‘ Šƒ††‡ dz•‡”–‡” ‘‰

„‹˜‹”‹‰‡”dzǡ‰‡‡”‡Ž–Šƒ††‡ŠÞ›‡”‡‹˜¤‡”‹„Ž‘†‡–ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡‡‡

†‡ •‘ ˜ƒ” dz‰‘†– •‡”–‡Ž‹†”‡– ‘‰ —–‡ „‹˜‹”‹‰‡”dzǤ ’‡•‹‡Ž– ‰ŒƒŽ†– †‡––‡ ˆ‘”

„‹˜‹”‹‰‡dz–”Þ––Ї–dzǡŠ˜‘”ƒ†‡Ž‡’ƒ•‹‡–‡”‡†dz•‡”–‡‘‰–”Þ––Ї–dz˜ƒ”›‡•–Þ””‡

‡ƒ†‡Ž‡dz‰‘†–•‡”–‡„‡Šƒ†Ž‡–‘‰‹‡–”Þ––dzǤ‹••‡”‡•—Ž–ƒ–‡‡ƒ–›†‡”ƒ–ƒ‰‡

’ƒ•‹‡–‡”‡””‡Žƒ–‹˜–‘˜‡”†‘•‡”–ǡ‘‰ƒ•Œ‡„—”†‡˜§”––‹Ž„—†–‡–ƒ‡–‡†‹ƒ‡–‡

‘•›‘†‘Ǥ

–—†‹‡ ˜‹•–‡ ‘‰•¤ ƒ– CYP2D6 ‰‡ ˜ƒ”‹ƒ–‡ ’¤˜‹”‡” ‹˜¤‡– ƒ˜ ‘›‘”ˆ‘ ‘‰

‘”‘•›‘”ˆ‘ ‹ „Ž‘†‡–ǡ ‡ †‡––‡ Šƒ††‡ ‹‰‡ „‡–›†‹‰ ˆ‘” ˜‹”‹‰‡ ƒ˜

‘•›‘†‘„‡Šƒ†Ž‹‰‡Ǥ

– †‡ •—„Œ‡–‹˜‡ —–ˆƒŽŽ••›’–‘‡‡ •‡”–‡‹–‡•‹–‡–ǡ –”‡––Ї–ǡ ˜ƒŽ‡ ‘‰ ‘‰‹–‹˜

ˆ—•Œ‘ ‹‡ „ƒ”‡ •›Ž†‡• ‘•›‘†‘„‡Šƒ†Ž‹‰‡ǡ ‡ ‘‰•¤ •‡Ž˜‡ ”‡ˆ–•›†‘‡ǡ

‰‹”—–ˆ‘”†”‹‰‡”‹–‘Ž‹‰‡ƒ˜”‡•—Ž–ƒ–‡‡Ǥ

’’•—‡”– ‹†‹‡”‡” †‡‡ •–—†‹‡ ƒ– ˜‡”‡ ”—–‹‡‡••‹‰

•‡”—‘•‡–”ƒ•Œ‘•¤Ž‹‰ ‡ŽŽ‡” ‰‡‘–›’‹‰ ƒ˜ CYP2D6 ‡” ‹†‹•‡”– ˜‡† „”— ƒ˜

‘•›‘†‘Ǥ‡†”‘‹•ƒ†‹‹•–”‡”‹‰‡”‘•›‘†‘†‡–˜‡•‡–Ž‹‰‡ǡƒ–‹˜‡˜‹”‡•–‘ˆˆ‡–Ǥ

”Þ––Ї– ‡” ‡– Š›’’‹‰ •›’–‘ Š‘• †‡ •‘ ‹‡ ‡” ‰‘†– •‡”–‡„‡Šƒ†Ž‡– ‘‰ ƒ

‹†‹‡”‡ „‡Š‘˜ ˆ‘” ¤ „›––‡ ‘’‹‘‹†Ǥ ƒ•‹‡–‡” •‘ •ƒŽ •–ƒ”–‡ ‡ŽŽ‡” •–‘’’‡ ‡† ͵Ͷ

‡†‹ƒ‡–‡”„Þ”ˆÞމ‡•–‡––‡––‡”’¤Ǥ

Cand.ScientTrineNaalsundAndreassen

‹˜¤‡–ƒ˜‘•›‘†‘‹„Ž‘†‡–‘‰ˆ‘”Бކ‡–‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘Ǥ”—ƒ˜‡†‹ƒ‡–‡”

•‘Š‡‡”ʹ͸‡œ›‡‡Šƒ††‡‹‰‡„‡–›†‹‰ˆ‘”‹˜¤‡–ƒ˜‘•›‘†‘‡ŽŽ‡”

‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘ˆ‘”Бކ‡–‹„Ž‘†‡–Ǥ

‡– ˜ƒ” ‹‰‡ •ƒ‡Š‡‰ ‡ŽŽ‘ ‹˜¤‡– ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‡–ƒ„‘Ž‹––‡‡

‘”‘•›‘†‘‘‰‘”‘•›‘”ˆ‘‹„Ž‘†‡–‘‰•‡”–‡‹–‡•‹–‡–ǡ‘‰„‹˜‹”‹‰‡”ȋ˜ƒŽ‡ǡ

–”Þ––Ї– ‘‰ ‘‰‹–‹˜ ˆ—•Œ‘ȌǤ ‹‡˜‡Ž ˜ƒ” „”— ƒ˜ ͵Ͷ Ї‡”‡ ˆŽ—‘ƒœ‘Ž

ƒ••‘•‹‡”–‡†‹†”‡•‡”–‡ǡ‡•ލ–‡‰†‡ƒ˜‡–ƒ„‘Ž‹––‡‘•›‘”ˆ‘’ƒ”†‘•ƒŽ–

‘ ˜ƒ” ƒ••‘•‹‡”– ‡† ‡ ލ‹‰ ‹ •‡”–‡ ‹ †‡‡ ‰”—’’‡ ƒ˜ ’ƒ•‹‡–‡”Ǥ ‡––‡ ‡”

˜ƒ•‡Ž‹‰ ¤ ˆ‘”Žƒ”‡ǡ ‡ ˜‹ ‘„•‡”˜‡”–‡ ‘‰•¤ ƒ– ’ƒ•‹‡–‡” •‘ Šƒ††‡ dz•‡”–‡” ‘‰

„‹˜‹”‹‰‡”dzǡ‰‡‡”‡Ž–Šƒ††‡ŠÞ›‡”‡‹˜¤‡”‹„Ž‘†‡–ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡‡‡

†‡ •‘ ˜ƒ” dz‰‘†– •‡”–‡Ž‹†”‡– ‘‰ —–‡ „‹˜‹”‹‰‡”dzǤ ’‡•‹‡Ž– ‰ŒƒŽ†– †‡––‡ ˆ‘”

„‹˜‹”‹‰‡dz–”Þ––Ї–dzǡŠ˜‘”ƒ†‡Ž‡’ƒ•‹‡–‡”‡†dz•‡”–‡‘‰–”Þ––Ї–dz˜ƒ”›‡•–Þ””‡

‡ƒ†‡Ž‡dz‰‘†–•‡”–‡„‡Šƒ†Ž‡–‘‰‹‡–”Þ––dzǤ‹••‡”‡•—Ž–ƒ–‡‡ƒ–›†‡”ƒ–ƒ‰‡

’ƒ•‹‡–‡”‡””‡Žƒ–‹˜–‘˜‡”†‘•‡”–ǡ‘‰ƒ•Œ‡„—”†‡˜§”––‹Ž„—†–‡–ƒ‡–‡†‹ƒ‡–‡

‘•›‘†‘Ǥ

–—†‹‡ ˜‹•–‡ ‘‰•¤ ƒ– CYP2D6 ‰‡ ˜ƒ”‹ƒ–‡ ’¤˜‹”‡” ‹˜¤‡– ƒ˜ ‘›‘”ˆ‘ ‘‰

‘”‘•›‘”ˆ‘ ‹ „Ž‘†‡–ǡ ‡ †‡––‡ Šƒ††‡ ‹‰‡ „‡–›†‹‰ ˆ‘” ˜‹”‹‰‡ ƒ˜

‘•›‘†‘„‡Šƒ†Ž‹‰‡Ǥ

– †‡ •—„Œ‡–‹˜‡ —–ˆƒŽŽ••›’–‘‡‡ •‡”–‡‹–‡•‹–‡–ǡ –”‡––Ї–ǡ ˜ƒŽ‡ ‘‰ ‘‰‹–‹˜

ˆ—•Œ‘ ‹‡ „ƒ”‡ •›Ž†‡• ‘•›‘†‘„‡Šƒ†Ž‹‰‡ǡ ‡ ‘‰•¤ •‡Ž˜‡ ”‡ˆ–•›†‘‡ǡ

‰‹”—–ˆ‘”†”‹‰‡”‹–‘Ž‹‰‡ƒ˜”‡•—Ž–ƒ–‡‡Ǥ

’’•—‡”– ‹†‹‡”‡” †‡‡ •–—†‹‡ ƒ– ˜‡”‡ ”—–‹‡‡••‹‰

•‡”—‘•‡–”ƒ•Œ‘•¤Ž‹‰ ‡ŽŽ‡” ‰‡‘–›’‹‰ ƒ˜ CYP2D6 ‡” ‹†‹•‡”– ˜‡† „”— ƒ˜

‘•›‘†‘Ǥ‡†”‘‹•ƒ†‹‹•–”‡”‹‰‡”‘•›‘†‘†‡–˜‡•‡–Ž‹‰‡ǡƒ–‹˜‡˜‹”‡•–‘ˆˆ‡–Ǥ

”Þ––Ї– ‡” ‡– Š›’’‹‰ •›’–‘ Š‘• †‡ •‘ ‹‡ ‡” ‰‘†– •‡”–‡„‡Šƒ†Ž‡– ‘‰ ƒ

‹†‹‡”‡ „‡Š‘˜ ˆ‘” ¤ „›––‡ ‘’‹‘‹†Ǥ ƒ•‹‡–‡” •‘ •ƒŽ •–ƒ”–‡ ‡ŽŽ‡” •–‘’’‡ ‡† ͵Ͷ

‡†‹ƒ‡–‡”„Þ”ˆÞމ‡•–‡––‡––‡”’¤Ǥ

Cand.ScientTrineNaalsundAndreassen

‹˜¤‡–ƒ˜‘•›‘†‘‹„Ž‘†‡–‘‰ˆ‘”Бކ‡–‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘Ǥ”—ƒ˜‡†‹ƒ‡–‡”

•‘Š‡‡”ʹ͸‡œ›‡‡Šƒ††‡‹‰‡„‡–›†‹‰ˆ‘”‹˜¤‡–ƒ˜‘•›‘†‘‡ŽŽ‡”

‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘ˆ‘”Бކ‡–‹„Ž‘†‡–Ǥ

‡– ˜ƒ” ‹‰‡ •ƒ‡Š‡‰ ‡ŽŽ‘ ‹˜¤‡– ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‡–ƒ„‘Ž‹––‡‡

‘”‘•›‘†‘‘‰‘”‘•›‘”ˆ‘‹„Ž‘†‡–‘‰•‡”–‡‹–‡•‹–‡–ǡ‘‰„‹˜‹”‹‰‡”ȋ˜ƒŽ‡ǡ

–”Þ––Ї– ‘‰ ‘‰‹–‹˜ ˆ—•Œ‘ȌǤ ‹‡˜‡Ž ˜ƒ” „”— ƒ˜ ͵Ͷ Ї‡”‡ ˆŽ—‘ƒœ‘Ž

ƒ••‘•‹‡”–‡†‹†”‡•‡”–‡ǡ‡•ލ–‡‰†‡ƒ˜‡–ƒ„‘Ž‹––‡‘•›‘”ˆ‘’ƒ”†‘•ƒŽ–

‘ ˜ƒ” ƒ••‘•‹‡”– ‡† ‡ ލ‹‰ ‹ •‡”–‡ ‹ †‡‡ ‰”—’’‡ ƒ˜ ’ƒ•‹‡–‡”Ǥ ‡––‡ ‡”

˜ƒ•‡Ž‹‰ ¤ ˆ‘”Žƒ”‡ǡ ‡ ˜‹ ‘„•‡”˜‡”–‡ ‘‰•¤ ƒ– ’ƒ•‹‡–‡” •‘ Šƒ††‡ dz•‡”–‡” ‘‰

„‹˜‹”‹‰‡”dzǡ‰‡‡”‡Ž–Šƒ††‡ŠÞ›‡”‡‹˜¤‡”‹„Ž‘†‡–ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡‡‡

†‡ •‘ ˜ƒ” dz‰‘†– •‡”–‡Ž‹†”‡– ‘‰ —–‡ „‹˜‹”‹‰‡”dzǤ ’‡•‹‡Ž– ‰ŒƒŽ†– †‡––‡ ˆ‘”

„‹˜‹”‹‰‡dz–”Þ––Ї–dzǡŠ˜‘”ƒ†‡Ž‡’ƒ•‹‡–‡”‡†dz•‡”–‡‘‰–”Þ––Ї–dz˜ƒ”›‡•–Þ””‡

‡ƒ†‡Ž‡dz‰‘†–•‡”–‡„‡Šƒ†Ž‡–‘‰‹‡–”Þ––dzǤ‹••‡”‡•—Ž–ƒ–‡‡ƒ–›†‡”ƒ–ƒ‰‡

’ƒ•‹‡–‡”‡””‡Žƒ–‹˜–‘˜‡”†‘•‡”–ǡ‘‰ƒ•Œ‡„—”†‡˜§”––‹Ž„—†–‡–ƒ‡–‡†‹ƒ‡–‡

‘•›‘†‘Ǥ

–—†‹‡ ˜‹•–‡ ‘‰•¤ ƒ– CYP2D6 ‰‡ ˜ƒ”‹ƒ–‡ ’¤˜‹”‡” ‹˜¤‡– ƒ˜ ‘›‘”ˆ‘ ‘‰

‘”‘•›‘”ˆ‘ ‹ „Ž‘†‡–ǡ ‡ †‡––‡ Šƒ††‡ ‹‰‡ „‡–›†‹‰ ˆ‘” ˜‹”‹‰‡ ƒ˜

‘•›‘†‘„‡Šƒ†Ž‹‰‡Ǥ

– †‡ •—„Œ‡–‹˜‡ —–ˆƒŽŽ••›’–‘‡‡ •‡”–‡‹–‡•‹–‡–ǡ –”‡––Ї–ǡ ˜ƒŽ‡ ‘‰ ‘‰‹–‹˜

ˆ—•Œ‘ ‹‡ „ƒ”‡ •›Ž†‡• ‘•›‘†‘„‡Šƒ†Ž‹‰‡ǡ ‡ ‘‰•¤ •‡Ž˜‡ ”‡ˆ–•›†‘‡ǡ

‰‹”—–ˆ‘”†”‹‰‡”‹–‘Ž‹‰‡ƒ˜”‡•—Ž–ƒ–‡‡Ǥ

’’•—‡”– ‹†‹‡”‡” †‡‡ •–—†‹‡ ƒ– ˜‡”‡ ”—–‹‡‡••‹‰

•‡”—‘•‡–”ƒ•Œ‘•¤Ž‹‰ ‡ŽŽ‡” ‰‡‘–›’‹‰ ƒ˜ CYP2D6 ‡” ‹†‹•‡”– ˜‡† „”— ƒ˜

‘•›‘†‘Ǥ‡†”‘‹•ƒ†‹‹•–”‡”‹‰‡”‘•›‘†‘†‡–˜‡•‡–Ž‹‰‡ǡƒ–‹˜‡˜‹”‡•–‘ˆˆ‡–Ǥ

”Þ––Ї– ‡” ‡– Š›’’‹‰ •›’–‘ Š‘• †‡ •‘ ‹‡ ‡” ‰‘†– •‡”–‡„‡Šƒ†Ž‡– ‘‰ ƒ

‹†‹‡”‡ „‡Š‘˜ ˆ‘” ¤ „›––‡ ‘’‹‘‹†Ǥ ƒ•‹‡–‡” •‘ •ƒŽ •–ƒ”–‡ ‡ŽŽ‡” •–‘’’‡ ‡† ͵Ͷ

‡†‹ƒ‡–‡”„Þ”ˆÞމ‡•–‡––‡––‡”’¤Ǥ

Cand.ScientTrineNaalsundAndreassen

‹˜¤‡–ƒ˜‘•›‘†‘‹„Ž‘†‡–‘‰ˆ‘”Бކ‡–‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘Ǥ”—ƒ˜‡†‹ƒ‡–‡”

•‘Š‡‡”ʹ͸‡œ›‡‡Šƒ††‡‹‰‡„‡–›†‹‰ˆ‘”‹˜¤‡–ƒ˜‘•›‘†‘‡ŽŽ‡”

‡–ƒ„‘Ž‹––Ȁ‘•›‘†‘ˆ‘”Бކ‡–‹„Ž‘†‡–Ǥ

‡– ˜ƒ” ‹‰‡ •ƒ‡Š‡‰ ‡ŽŽ‘ ‹˜¤‡– ƒ˜ ‘•›‘†‘ ‡ŽŽ‡” ‡–ƒ„‘Ž‹––‡‡

‘”‘•›‘†‘‘‰‘”‘•›‘”ˆ‘‹„Ž‘†‡–‘‰•‡”–‡‹–‡•‹–‡–ǡ‘‰„‹˜‹”‹‰‡”ȋ˜ƒŽ‡ǡ

–”Þ––Ї– ‘‰ ‘‰‹–‹˜ ˆ—•Œ‘ȌǤ ‹‡˜‡Ž ˜ƒ” „”— ƒ˜ ͵Ͷ Ї‡”‡ ˆŽ—‘ƒœ‘Ž

ƒ••‘•‹‡”–‡†‹†”‡•‡”–‡ǡ‡•ލ–‡‰†‡ƒ˜‡–ƒ„‘Ž‹––‡‘•›‘”ˆ‘’ƒ”†‘•ƒŽ–

‘ ˜ƒ” ƒ••‘•‹‡”– ‡† ‡ ލ‹‰ ‹ •‡”–‡ ‹ †‡‡ ‰”—’’‡ ƒ˜ ’ƒ•‹‡–‡”Ǥ ‡––‡ ‡”

˜ƒ•‡Ž‹‰ ¤ ˆ‘”Žƒ”‡ǡ ‡ ˜‹ ‘„•‡”˜‡”–‡ ‘‰•¤ ƒ– ’ƒ•‹‡–‡” •‘ Šƒ††‡ dz•‡”–‡” ‘‰

„‹˜‹”‹‰‡”dzǡ‰‡‡”‡Ž–Šƒ††‡ŠÞ›‡”‡‹˜¤‡”‹„Ž‘†‡–ƒ˜‘•›‘†‘‘‰‡–ƒ„‘Ž‹––‡‡‡

†‡ •‘ ˜ƒ” dz‰‘†– •‡”–‡Ž‹†”‡– ‘‰ —–‡ „‹˜‹”‹‰‡”dzǤ ’‡•‹‡Ž– ‰ŒƒŽ†– †‡––‡ ˆ‘”

„‹˜‹”‹‰‡dz–”Þ––Ї–dzǡŠ˜‘”ƒ†‡Ž‡’ƒ•‹‡–‡”‡†dz•‡”–‡‘‰–”Þ––Ї–dz˜ƒ”›‡•–Þ””‡

‡ƒ†‡Ž‡dz‰‘†–•‡”–‡„‡Šƒ†Ž‡–‘‰‹‡–”Þ––dzǤ‹••‡”‡•—Ž–ƒ–‡‡ƒ–›†‡”ƒ–ƒ‰‡

’ƒ•‹‡–‡”‡””‡Žƒ–‹˜–‘˜‡”†‘•‡”–ǡ‘‰ƒ•Œ‡„—”†‡˜§”––‹Ž„—†–‡–ƒ‡–‡†‹ƒ‡–‡

‘•›‘†‘Ǥ

–—†‹‡ ˜‹•–‡ ‘‰•¤ ƒ– CYP2D6 ‰‡ ˜ƒ”‹ƒ–‡ ’¤˜‹”‡” ‹˜¤‡– ƒ˜ ‘›‘”ˆ‘ ‘‰

‘”‘•›‘”ˆ‘ ‹ „Ž‘†‡–ǡ ‡ †‡––‡ Šƒ††‡ ‹‰‡ „‡–›†‹‰ ˆ‘” ˜‹”‹‰‡ ƒ˜

‘•›‘†‘„‡Šƒ†Ž‹‰‡Ǥ

– †‡ •—„Œ‡–‹˜‡ —–ˆƒŽŽ••›’–‘‡‡ •‡”–‡‹–‡•‹–‡–ǡ –”‡––Ї–ǡ ˜ƒŽ‡ ‘‰ ‘‰‹–‹˜

ˆ—•Œ‘ ‹‡ „ƒ”‡ •›Ž†‡• ‘•›‘†‘„‡Šƒ†Ž‹‰‡ǡ ‡ ‘‰•¤ •‡Ž˜‡ ”‡ˆ–•›†‘‡ǡ

‰‹”—–ˆ‘”†”‹‰‡”‹–‘Ž‹‰‡ƒ˜”‡•—Ž–ƒ–‡‡Ǥ

’’•—‡”– ‹†‹‡”‡” †‡‡ •–—†‹‡ ƒ– ˜‡”‡ ”—–‹‡‡••‹‰

•‡”—‘•‡–”ƒ•Œ‘•¤Ž‹‰ ‡ŽŽ‡” ‰‡‘–›’‹‰ ƒ˜ CYP2D6 ‡” ‹†‹•‡”– ˜‡† „”— ƒ˜

‘•›‘†‘Ǥ‡†”‘‹•ƒ†‹‹•–”‡”‹‰‡”‘•›‘†‘†‡–˜‡•‡–Ž‹‰‡ǡƒ–‹˜‡˜‹”‡•–‘ˆˆ‡–Ǥ

”Þ––Ї– ‡” ‡– Š›’’‹‰ •›’–‘ Š‘• †‡ •‘ ‹‡ ‡” ‰‘†– •‡”–‡„‡Šƒ†Ž‡– ‘‰ ƒ

‹†‹‡”‡ „‡Š‘˜ ˆ‘” ¤ „›––‡ ‘’‹‘‹†Ǥ ƒ•‹‡–‡” •‘ •ƒŽ •–ƒ”–‡ ‡ŽŽ‡” •–‘’’‡ ‡† ͵Ͷ

‡†‹ƒ‡–‡”„Þ”ˆÞމ‡•–‡––‡––‡”’¤Ǥ

Cand.ScientTrineNaalsundAndreassen

(6)

Forskningsgruppe:Smerteogpalliasjon

Instituttforsirkulasjonogbildediagnostikk,DetMedisinskeFakultet,NTNU

Hovedveileder:ProfessorOlaDale

Biveiledere:ProfessorPålKlepstad,ProfessorSteinKaasaogPh.D.IngridEftedal

˜‡”‡˜–‡ƒ˜Šƒ†Ž‹‰‡”ˆ—‡–˜‡”†‹‰–‹Ž¤ˆ‘”•˜ƒ”‡•‘ˆˆ‡–Ž‹‰

ˆ‘”‰”ƒ†‡ŠǤǤ‹Ž‹‹•‡†‹•‹Ǥ

‹•’—–ƒ•‡ˆ‹‡”•–‡†‹ǡ—†‹–‘”‹—ǡ‡†‹•‹•–‡‹•ˆ‘”•‹‰••‡–‡”ǡ

–‘”•†ƒ‰ʹ͵ǤŒ—‹ʹͲͳͳǡŽ‘‡ͳʹǤͳͷ

Forskningsgruppe:Smerteogpalliasjon

Instituttforsirkulasjonogbildediagnostikk,DetMedisinskeFakultet,NTNU

Hovedveileder:ProfessorOlaDale

Biveiledere:ProfessorPålKlepstad,ProfessorSteinKaasaogPh.D.IngridEftedal

˜‡”‡˜–‡ƒ˜Šƒ†Ž‹‰‡”ˆ—‡–˜‡”†‹‰–‹Ž¤ˆ‘”•˜ƒ”‡•‘ˆˆ‡–Ž‹‰

ˆ‘”‰”ƒ†‡ŠǤǤ‹Ž‹‹•‡†‹•‹Ǥ

‹•’—–ƒ•‡ˆ‹‡”•–‡†‹ǡ—†‹–‘”‹—ǡ‡†‹•‹•–‡‹•ˆ‘”•‹‰••‡–‡”ǡ

–‘”•†ƒ‰ʹ͵ǤŒ—‹ʹͲͳͳǡŽ‘‡ͳʹǤͳͷ

Forskningsgruppe:Smerteogpalliasjon

Instituttforsirkulasjonogbildediagnostikk,DetMedisinskeFakultet,NTNU

Hovedveileder:ProfessorOlaDale

Biveiledere:ProfessorPålKlepstad,ProfessorSteinKaasaogPh.D.IngridEftedal

˜‡”‡˜–‡ƒ˜Šƒ†Ž‹‰‡”ˆ—‡–˜‡”†‹‰–‹Ž¤ˆ‘”•˜ƒ”‡•‘ˆˆ‡–Ž‹‰

ˆ‘”‰”ƒ†‡ŠǤǤ‹Ž‹‹•‡†‹•‹Ǥ

‹•’—–ƒ•‡ˆ‹‡”•–‡†‹ǡ—†‹–‘”‹—ǡ‡†‹•‹•–‡‹•ˆ‘”•‹‰••‡–‡”ǡ

–‘”•†ƒ‰ʹ͵ǤŒ—‹ʹͲͳͳǡŽ‘‡ͳʹǤͳͷ

Forskningsgruppe:Smerteogpalliasjon

Instituttforsirkulasjonogbildediagnostikk,DetMedisinskeFakultet,NTNU

Hovedveileder:ProfessorOlaDale

Biveiledere:ProfessorPålKlepstad,ProfessorSteinKaasaogPh.D.IngridEftedal

˜‡”‡˜–‡ƒ˜Šƒ†Ž‹‰‡”ˆ—‡–˜‡”†‹‰–‹Ž¤ˆ‘”•˜ƒ”‡•‘ˆˆ‡–Ž‹‰

ˆ‘”‰”ƒ†‡ŠǤǤ‹Ž‹‹•‡†‹•‹Ǥ

‹•’—–ƒ•‡ˆ‹‡”•–‡†‹ǡ—†‹–‘”‹—ǡ‡†‹•‹•–‡‹•ˆ‘”•‹‰••‡–‡”ǡ

–‘”•†ƒ‰ʹ͵ǤŒ—‹ʹͲͳͳǡŽ‘‡ͳʹǤͳͷ

(7)
(8)

Summary

Š”‘‹…’ƒ‹†—”‹‰…ƒ…‡”‹•ƒ…ŠƒŽŽ‡‰‹‰’”‘„އǤ˜‡–Š‘—‰Š•–”‘‰†”—‰•ˆ‘”’ƒ‹

”‡Ž‹‡ˆ•—…Šƒ•‘”’Š‹‡‘”‘š›…‘†‘‡ȋ‘’‹‘‹†•Ȍƒ”‡‡š–‡•‹˜‡Ž›—•‡†ǡƒ›…ƒ…‡”

’ƒ–‹‡–•ƒ”‡‹ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹˜‡†‘”•—ˆˆ‡”‹‰ˆ”‘•‹†‡‡ˆˆ‡…–•ǤŠ‡Žƒ”‰‡‹–‡”Ǧ

‹†‹˜‹†—ƒŽ˜ƒ”‹ƒ„‹Ž‹–›‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•‹•‘‡”‡ƒ•‘™Š›ƒŽŽ’ƒ–‹‡–•ƒ”‡‘–

ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹‡˜‡†Ǥ‘„‡ƒ„އ–‘‡•—”‡ƒ„‡––‡”–”‡ƒ–‡––‘…ƒ…‡”’ƒ–‹‡–•‹–‹•

‹’‘”–ƒ––‘—†‡”•–ƒ†™Š›–Ї”‡‹••—…Š˜ƒ”‹ƒ–‹‘‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•Ǥ

Š‹••–—†›‹•’ƒ”–‘ˆƒŽƒ”‰‡”Ǧ’”‘Œ‡…––Šƒ–‹…Ž—†‡†ʹʹͻͶ…ƒ…‡”’ƒ–‹‡–•Ǥˆ–Ї•‡ǡͶ͸ͳ

™‡”‡•…Ї†—އ†™‹–ЖЇ‘’‹‘‹†‘š›…‘†‘‡ˆ‘”–Ї‹”…ƒ…‡”’ƒ‹ǤЇ”‡‹•Ž‹––އ

‘™Ž‡†‰‡ƒ„‘—–™Š‹…Šˆƒ…–‘”•–Šƒ–‹ˆŽ—‡…‡•–Ї‡ˆˆ‹…ƒ…›‘ˆ‘š›…‘†‘‡‹…ƒ…‡”

’ƒ–‹‡–•ǤŠ—•ǡ–Їƒ‹‘ˆ–Š‹••–—†›™ƒ•–‘‡šƒ‹‡‹ˆ…Ž‹‹…ƒŽ‹ˆ‘”ƒ–‹‘–‘‰‡–Ї”™‹–Š

‡ƒ•—”‡‡–•‘ˆ•‡”—…‘…‡–”ƒ–‹‘•‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‘”‰‡‡•‘ˆ–Ї

‡–ƒ„‘Ž‹œ‹‰‡œ›‡•ǡƒ›‡š’Žƒ‹†‹ˆˆ‡”‡…‡•„‡–™‡‡‹†‹˜‹†—ƒŽ•ǤŽ‹‹…ƒŽ

‹ˆ‘”ƒ–‹‘‹…Ž—†‡†™ƒ•–Ї’ƒ–‹‡–ǯ•ƒ‰‡ǡ•‡šǡ„‘†›ƒ••‹†‡šǡ‘š›…‘†‘‡†ƒ‹Ž›

†‘•ƒ‰‡ǡ‹ˆ‘”ƒ–‹‘‘…‘Ǧ‡†‹…ƒ–‹‘ǡŠ‘™Ž‘‰–Ї’ƒ–‹‡–Šƒ•„‡‡—•‹‰‘’‹‘‹†•ǡ

—„‡”‘ˆŠ‘—”••‹…‡Žƒ•–†‘•‡ǡ’Š›•‹…ƒŽˆ—…–‹‘‹‰ǡƒ†‹†‹…ƒ–‘”•ˆ‘”Ї’ƒ–‹…Ǧƒ†

‹†‡›ˆ—…–‹‘Ǥ

š›…‘†‘‡‹•ƒ‹Ž›‡–ƒ„‘Ž‹œ‡†‹–Їދ˜‡”„›͵Ͷƒ†ʹ͸‡œ›‡•ǤЇ

ƒ…–‹˜‹–›‘ˆ–Ї•‡‡œ›‡•ƒ›„‡ƒˆˆ‡…–‡†„›‘–Ї”†”—‰•—•‡†„›–Ї’ƒ–‹‡–Ǥ

ƒ††‹–‹‘ǡ–ЇCYP2D6‰‡‡‡š‹•–•‹•‡˜‡”ƒŽˆ‘”•–Šƒ–ƒˆˆ‡…––Ї’”‘†—…–‹‘‘ˆ–Ї

ƒƒŽ‰‡•‹…‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡Ǥ‘Ǧ‡†‹…ƒ–‹‘ƒ†CYP2D6‰‡‡–‹…˜ƒ”‹ƒ–•…ƒ

–Ї”‡ˆ‘”‡ƒˆˆ‡…––Їއ˜‡Ž‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‹–Ї‹†‹˜‹†—ƒŽ’ƒ–‹‡–ǯ•

„Ž‘‘†ǤŠ‹•…ƒŠƒ˜‡‹’Ž‹…ƒ–‹‘•ˆ‘”–Ї”‡“—‹”‡††‘•‡‘ˆ‘š›…‘†‘‡Ǥ

Ї•–—†›Šƒ••Š‘™–Šƒ––Ї˜ƒ”‹ƒ„އDz†ƒ‹Ž›†‘•‡‘ˆ‘š›…‘†‘‡dz„‡•–‡š’Žƒ‹‡†–Ї

˜ƒ”‹ƒ–‹‘‹„Ž‘‘†Ž‡˜‡Žǡ™Š‹Ž‡•‡šƒ†—•‡‘ˆ…‘Ǧ‡†‹…ƒ–‹‘•–Šƒ–ƒˆˆ‡…–•–Ї‡–ƒ„‘Ž‹•

‘ˆ‘š›…‘†‘‡˜‹ƒ͵Ͷ‡œ›‡•ǡŠƒ†–Š‡Žƒ”‰‡•–‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‹

–Ї„Ž‘‘†ƒ†–Ї”ƒ–‹‘‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡Ǥ•‡‘ˆ†”—‰•–Šƒ–‹Š‹„‹–ʹ͸

‡œ›‡•Šƒ†‘‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡”ƒ–‹‘‹

–Ї„Ž‘‘†Ǥ

‘”‡Žƒ–‹‘•Š‹’™ƒ•ˆ‘—†„‡–™‡‡Ž‡˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡•‘”‘š›…‘†‘‡

ƒ†‘”‘š›‘”’Š‘‡‹–Ї„Ž‘‘†ƒ†’ƒ‹‹–‡•‹–›ǡƒ†•‹†‡‡ˆˆ‡…–•ȋƒ—•‡ƒǡ–‹”‡†‡••

Summary

Š”‘‹…’ƒ‹†—”‹‰…ƒ…‡”‹•ƒ…ŠƒŽŽ‡‰‹‰’”‘„އǤ˜‡–Š‘—‰Š•–”‘‰†”—‰•ˆ‘”’ƒ‹

”‡Ž‹‡ˆ•—…Šƒ•‘”’Š‹‡‘”‘š›…‘†‘‡ȋ‘’‹‘‹†•Ȍƒ”‡‡š–‡•‹˜‡Ž›—•‡†ǡƒ›…ƒ…‡”

’ƒ–‹‡–•ƒ”‡‹ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹˜‡†‘”•—ˆˆ‡”‹‰ˆ”‘•‹†‡‡ˆˆ‡…–•ǤŠ‡Žƒ”‰‡‹–‡”Ǧ

‹†‹˜‹†—ƒŽ˜ƒ”‹ƒ„‹Ž‹–›‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•‹•‘‡”‡ƒ•‘™Š›ƒŽŽ’ƒ–‹‡–•ƒ”‡‘–

ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹‡˜‡†Ǥ‘„‡ƒ„އ–‘‡•—”‡ƒ„‡––‡”–”‡ƒ–‡––‘…ƒ…‡”’ƒ–‹‡–•‹–‹•

‹’‘”–ƒ––‘—†‡”•–ƒ†™Š›–Ї”‡‹••—…Š˜ƒ”‹ƒ–‹‘‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•Ǥ

Š‹••–—†›‹•’ƒ”–‘ˆƒŽƒ”‰‡”Ǧ’”‘Œ‡…––Šƒ–‹…Ž—†‡†ʹʹͻͶ…ƒ…‡”’ƒ–‹‡–•Ǥˆ–Ї•‡ǡͶ͸ͳ

™‡”‡•…Ї†—އ†™‹–ЖЇ‘’‹‘‹†‘š›…‘†‘‡ˆ‘”–Ї‹”…ƒ…‡”’ƒ‹ǤЇ”‡‹•Ž‹––އ

‘™Ž‡†‰‡ƒ„‘—–™Š‹…Šˆƒ…–‘”•–Šƒ–‹ˆŽ—‡…‡•–Ї‡ˆˆ‹…ƒ…›‘ˆ‘š›…‘†‘‡‹…ƒ…‡”

’ƒ–‹‡–•ǤŠ—•ǡ–Їƒ‹‘ˆ–Š‹••–—†›™ƒ•–‘‡šƒ‹‡‹ˆ…Ž‹‹…ƒŽ‹ˆ‘”ƒ–‹‘–‘‰‡–Ї”™‹–Š

‡ƒ•—”‡‡–•‘ˆ•‡”—…‘…‡–”ƒ–‹‘•‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‘”‰‡‡•‘ˆ–Ї

‡–ƒ„‘Ž‹œ‹‰‡œ›‡•ǡƒ›‡š’Žƒ‹†‹ˆˆ‡”‡…‡•„‡–™‡‡‹†‹˜‹†—ƒŽ•ǤŽ‹‹…ƒŽ

‹ˆ‘”ƒ–‹‘‹…Ž—†‡†™ƒ•–Ї’ƒ–‹‡–ǯ•ƒ‰‡ǡ•‡šǡ„‘†›ƒ••‹†‡šǡ‘š›…‘†‘‡†ƒ‹Ž›

†‘•ƒ‰‡ǡ‹ˆ‘”ƒ–‹‘‘…‘Ǧ‡†‹…ƒ–‹‘ǡŠ‘™Ž‘‰–Ї’ƒ–‹‡–Šƒ•„‡‡—•‹‰‘’‹‘‹†•ǡ

—„‡”‘ˆŠ‘—”••‹…‡Žƒ•–†‘•‡ǡ’Š›•‹…ƒŽˆ—…–‹‘‹‰ǡƒ†‹†‹…ƒ–‘”•ˆ‘”Ї’ƒ–‹…Ǧƒ†

‹†‡›ˆ—…–‹‘Ǥ

š›…‘†‘‡‹•ƒ‹Ž›‡–ƒ„‘Ž‹œ‡†‹–Їދ˜‡”„›͵Ͷƒ†ʹ͸‡œ›‡•ǤЇ

ƒ…–‹˜‹–›‘ˆ–Ї•‡‡œ›‡•ƒ›„‡ƒˆˆ‡…–‡†„›‘–Ї”†”—‰•—•‡†„›–Ї’ƒ–‹‡–Ǥ

ƒ††‹–‹‘ǡ–ЇCYP2D6‰‡‡‡š‹•–•‹•‡˜‡”ƒŽˆ‘”•–Šƒ–ƒˆˆ‡…––Ї’”‘†—…–‹‘‘ˆ–Ї

ƒƒŽ‰‡•‹…‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡Ǥ‘Ǧ‡†‹…ƒ–‹‘ƒ†CYP2D6‰‡‡–‹…˜ƒ”‹ƒ–•…ƒ

–Ї”‡ˆ‘”‡ƒˆˆ‡…––Їއ˜‡Ž‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‹–Ї‹†‹˜‹†—ƒŽ’ƒ–‹‡–ǯ•

„Ž‘‘†ǤŠ‹•…ƒŠƒ˜‡‹’Ž‹…ƒ–‹‘•ˆ‘”–Ї”‡“—‹”‡††‘•‡‘ˆ‘š›…‘†‘‡Ǥ

Ї•–—†›Šƒ••Š‘™–Šƒ––Ї˜ƒ”‹ƒ„އDz†ƒ‹Ž›†‘•‡‘ˆ‘š›…‘†‘‡dz„‡•–‡š’Žƒ‹‡†–Ї

˜ƒ”‹ƒ–‹‘‹„Ž‘‘†Ž‡˜‡Žǡ™Š‹Ž‡•‡šƒ†—•‡‘ˆ…‘Ǧ‡†‹…ƒ–‹‘•–Šƒ–ƒˆˆ‡…–•–Ї‡–ƒ„‘Ž‹•

‘ˆ‘š›…‘†‘‡˜‹ƒ͵Ͷ‡œ›‡•ǡŠƒ†–Š‡Žƒ”‰‡•–‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‹

–Ї„Ž‘‘†ƒ†–Ї”ƒ–‹‘‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡Ǥ•‡‘ˆ†”—‰•–Šƒ–‹Š‹„‹–ʹ͸

‡œ›‡•Šƒ†‘‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡”ƒ–‹‘‹

–Ї„Ž‘‘†Ǥ

‘”‡Žƒ–‹‘•Š‹’™ƒ•ˆ‘—†„‡–™‡‡Ž‡˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡•‘”‘š›…‘†‘‡

ƒ†‘”‘š›‘”’Š‘‡‹–Ї„Ž‘‘†ƒ†’ƒ‹‹–‡•‹–›ǡƒ†•‹†‡‡ˆˆ‡…–•ȋƒ—•‡ƒǡ–‹”‡†‡••

Summary

Š”‘‹…’ƒ‹†—”‹‰…ƒ…‡”‹•ƒ…ŠƒŽŽ‡‰‹‰’”‘„އǤ˜‡–Š‘—‰Š•–”‘‰†”—‰•ˆ‘”’ƒ‹

”‡Ž‹‡ˆ•—…Šƒ•‘”’Š‹‡‘”‘š›…‘†‘‡ȋ‘’‹‘‹†•Ȍƒ”‡‡š–‡•‹˜‡Ž›—•‡†ǡƒ›…ƒ…‡”

’ƒ–‹‡–•ƒ”‡‹ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹˜‡†‘”•—ˆˆ‡”‹‰ˆ”‘•‹†‡‡ˆˆ‡…–•ǤŠ‡Žƒ”‰‡‹–‡”Ǧ

‹†‹˜‹†—ƒŽ˜ƒ”‹ƒ„‹Ž‹–›‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•‹•‘‡”‡ƒ•‘™Š›ƒŽŽ’ƒ–‹‡–•ƒ”‡‘–

ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹‡˜‡†Ǥ‘„‡ƒ„އ–‘‡•—”‡ƒ„‡––‡”–”‡ƒ–‡––‘…ƒ…‡”’ƒ–‹‡–•‹–‹•

‹’‘”–ƒ––‘—†‡”•–ƒ†™Š›–Ї”‡‹••—…Š˜ƒ”‹ƒ–‹‘‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•Ǥ

Š‹••–—†›‹•’ƒ”–‘ˆƒŽƒ”‰‡”Ǧ’”‘Œ‡…––Šƒ–‹…Ž—†‡†ʹʹͻͶ…ƒ…‡”’ƒ–‹‡–•Ǥˆ–Ї•‡ǡͶ͸ͳ

™‡”‡•…Ї†—އ†™‹–ЖЇ‘’‹‘‹†‘š›…‘†‘‡ˆ‘”–Ї‹”…ƒ…‡”’ƒ‹ǤЇ”‡‹•Ž‹––އ

‘™Ž‡†‰‡ƒ„‘—–™Š‹…Šˆƒ…–‘”•–Šƒ–‹ˆŽ—‡…‡•–Ї‡ˆˆ‹…ƒ…›‘ˆ‘š›…‘†‘‡‹…ƒ…‡”

’ƒ–‹‡–•ǤŠ—•ǡ–Їƒ‹‘ˆ–Š‹••–—†›™ƒ•–‘‡šƒ‹‡‹ˆ…Ž‹‹…ƒŽ‹ˆ‘”ƒ–‹‘–‘‰‡–Ї”™‹–Š

‡ƒ•—”‡‡–•‘ˆ•‡”—…‘…‡–”ƒ–‹‘•‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‘”‰‡‡•‘ˆ–Ї

‡–ƒ„‘Ž‹œ‹‰‡œ›‡•ǡƒ›‡š’Žƒ‹†‹ˆˆ‡”‡…‡•„‡–™‡‡‹†‹˜‹†—ƒŽ•ǤŽ‹‹…ƒŽ

‹ˆ‘”ƒ–‹‘‹…Ž—†‡†™ƒ•–Ї’ƒ–‹‡–ǯ•ƒ‰‡ǡ•‡šǡ„‘†›ƒ••‹†‡šǡ‘š›…‘†‘‡†ƒ‹Ž›

†‘•ƒ‰‡ǡ‹ˆ‘”ƒ–‹‘‘…‘Ǧ‡†‹…ƒ–‹‘ǡŠ‘™Ž‘‰–Ї’ƒ–‹‡–Šƒ•„‡‡—•‹‰‘’‹‘‹†•ǡ

—„‡”‘ˆŠ‘—”••‹…‡Žƒ•–†‘•‡ǡ’Š›•‹…ƒŽˆ—…–‹‘‹‰ǡƒ†‹†‹…ƒ–‘”•ˆ‘”Ї’ƒ–‹…Ǧƒ†

‹†‡›ˆ—…–‹‘Ǥ

š›…‘†‘‡‹•ƒ‹Ž›‡–ƒ„‘Ž‹œ‡†‹–Їދ˜‡”„›͵Ͷƒ†ʹ͸‡œ›‡•ǤЇ

ƒ…–‹˜‹–›‘ˆ–Ї•‡‡œ›‡•ƒ›„‡ƒˆˆ‡…–‡†„›‘–Ї”†”—‰•—•‡†„›–Ї’ƒ–‹‡–Ǥ

ƒ††‹–‹‘ǡ–ЇCYP2D6‰‡‡‡š‹•–•‹•‡˜‡”ƒŽˆ‘”•–Šƒ–ƒˆˆ‡…––Ї’”‘†—…–‹‘‘ˆ–Ї

ƒƒŽ‰‡•‹…‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡Ǥ‘Ǧ‡†‹…ƒ–‹‘ƒ†CYP2D6‰‡‡–‹…˜ƒ”‹ƒ–•…ƒ

–Ї”‡ˆ‘”‡ƒˆˆ‡…––Їއ˜‡Ž‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‹–Ї‹†‹˜‹†—ƒŽ’ƒ–‹‡–ǯ•

„Ž‘‘†ǤŠ‹•…ƒŠƒ˜‡‹’Ž‹…ƒ–‹‘•ˆ‘”–Ї”‡“—‹”‡††‘•‡‘ˆ‘š›…‘†‘‡Ǥ

Ї•–—†›Šƒ••Š‘™–Šƒ––Ї˜ƒ”‹ƒ„އDz†ƒ‹Ž›†‘•‡‘ˆ‘š›…‘†‘‡dz„‡•–‡š’Žƒ‹‡†–Ї

˜ƒ”‹ƒ–‹‘‹„Ž‘‘†Ž‡˜‡Žǡ™Š‹Ž‡•‡šƒ†—•‡‘ˆ…‘Ǧ‡†‹…ƒ–‹‘•–Šƒ–ƒˆˆ‡…–•–Ї‡–ƒ„‘Ž‹•

‘ˆ‘š›…‘†‘‡˜‹ƒ͵Ͷ‡œ›‡•ǡŠƒ†–Š‡Žƒ”‰‡•–‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‹

–Ї„Ž‘‘†ƒ†–Ї”ƒ–‹‘‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡Ǥ•‡‘ˆ†”—‰•–Šƒ–‹Š‹„‹–ʹ͸

‡œ›‡•Šƒ†‘‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡”ƒ–‹‘‹

–Ї„Ž‘‘†Ǥ

‘”‡Žƒ–‹‘•Š‹’™ƒ•ˆ‘—†„‡–™‡‡Ž‡˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡•‘”‘š›…‘†‘‡

ƒ†‘”‘š›‘”’Š‘‡‹–Ї„Ž‘‘†ƒ†’ƒ‹‹–‡•‹–›ǡƒ†•‹†‡‡ˆˆ‡…–•ȋƒ—•‡ƒǡ–‹”‡†‡••

Summary

Š”‘‹…’ƒ‹†—”‹‰…ƒ…‡”‹•ƒ…ŠƒŽŽ‡‰‹‰’”‘„އǤ˜‡–Š‘—‰Š•–”‘‰†”—‰•ˆ‘”’ƒ‹

”‡Ž‹‡ˆ•—…Šƒ•‘”’Š‹‡‘”‘š›…‘†‘‡ȋ‘’‹‘‹†•Ȍƒ”‡‡š–‡•‹˜‡Ž›—•‡†ǡƒ›…ƒ…‡”

’ƒ–‹‡–•ƒ”‡‹ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹˜‡†‘”•—ˆˆ‡”‹‰ˆ”‘•‹†‡‡ˆˆ‡…–•ǤŠ‡Žƒ”‰‡‹–‡”Ǧ

‹†‹˜‹†—ƒŽ˜ƒ”‹ƒ„‹Ž‹–›‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•‹•‘‡”‡ƒ•‘™Š›ƒŽŽ’ƒ–‹‡–•ƒ”‡‘–

ƒ†‡“—ƒ–‡Ž›’ƒ‹”‡Ž‹‡˜‡†Ǥ‘„‡ƒ„އ–‘‡•—”‡ƒ„‡––‡”–”‡ƒ–‡––‘…ƒ…‡”’ƒ–‹‡–•‹–‹•

‹’‘”–ƒ––‘—†‡”•–ƒ†™Š›–Ї”‡‹••—…Š˜ƒ”‹ƒ–‹‘‹–Ї”‡•’‘•‡–‘‘’‹‘‹†•Ǥ

Š‹••–—†›‹•’ƒ”–‘ˆƒŽƒ”‰‡”Ǧ’”‘Œ‡…––Šƒ–‹…Ž—†‡†ʹʹͻͶ…ƒ…‡”’ƒ–‹‡–•Ǥˆ–Ї•‡ǡͶ͸ͳ

™‡”‡•…Ї†—އ†™‹–ЖЇ‘’‹‘‹†‘š›…‘†‘‡ˆ‘”–Ї‹”…ƒ…‡”’ƒ‹ǤЇ”‡‹•Ž‹––އ

‘™Ž‡†‰‡ƒ„‘—–™Š‹…Šˆƒ…–‘”•–Šƒ–‹ˆŽ—‡…‡•–Ї‡ˆˆ‹…ƒ…›‘ˆ‘š›…‘†‘‡‹…ƒ…‡”

’ƒ–‹‡–•ǤŠ—•ǡ–Їƒ‹‘ˆ–Š‹••–—†›™ƒ•–‘‡šƒ‹‡‹ˆ…Ž‹‹…ƒŽ‹ˆ‘”ƒ–‹‘–‘‰‡–Ї”™‹–Š

‡ƒ•—”‡‡–•‘ˆ•‡”—…‘…‡–”ƒ–‹‘•‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‘”‰‡‡•‘ˆ–Ї

‡–ƒ„‘Ž‹œ‹‰‡œ›‡•ǡƒ›‡š’Žƒ‹†‹ˆˆ‡”‡…‡•„‡–™‡‡‹†‹˜‹†—ƒŽ•ǤŽ‹‹…ƒŽ

‹ˆ‘”ƒ–‹‘‹…Ž—†‡†™ƒ•–Ї’ƒ–‹‡–ǯ•ƒ‰‡ǡ•‡šǡ„‘†›ƒ••‹†‡šǡ‘š›…‘†‘‡†ƒ‹Ž›

†‘•ƒ‰‡ǡ‹ˆ‘”ƒ–‹‘‘…‘Ǧ‡†‹…ƒ–‹‘ǡŠ‘™Ž‘‰–Ї’ƒ–‹‡–Šƒ•„‡‡—•‹‰‘’‹‘‹†•ǡ

—„‡”‘ˆŠ‘—”••‹…‡Žƒ•–†‘•‡ǡ’Š›•‹…ƒŽˆ—…–‹‘‹‰ǡƒ†‹†‹…ƒ–‘”•ˆ‘”Ї’ƒ–‹…Ǧƒ†

‹†‡›ˆ—…–‹‘Ǥ

š›…‘†‘‡‹•ƒ‹Ž›‡–ƒ„‘Ž‹œ‡†‹–Їދ˜‡”„›͵Ͷƒ†ʹ͸‡œ›‡•ǤЇ

ƒ…–‹˜‹–›‘ˆ–Ї•‡‡œ›‡•ƒ›„‡ƒˆˆ‡…–‡†„›‘–Ї”†”—‰•—•‡†„›–Ї’ƒ–‹‡–Ǥ

ƒ††‹–‹‘ǡ–ЇCYP2D6‰‡‡‡š‹•–•‹•‡˜‡”ƒŽˆ‘”•–Šƒ–ƒˆˆ‡…––Ї’”‘†—…–‹‘‘ˆ–Ї

ƒƒŽ‰‡•‹…‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡Ǥ‘Ǧ‡†‹…ƒ–‹‘ƒ†CYP2D6‰‡‡–‹…˜ƒ”‹ƒ–•…ƒ

–Ї”‡ˆ‘”‡ƒˆˆ‡…––Їއ˜‡Ž‘ˆ‘š›…‘†‘‡ƒ†‹–•‡–ƒ„‘Ž‹–‡•‹–Ї‹†‹˜‹†—ƒŽ’ƒ–‹‡–ǯ•

„Ž‘‘†ǤŠ‹•…ƒŠƒ˜‡‹’Ž‹…ƒ–‹‘•ˆ‘”–Ї”‡“—‹”‡††‘•‡‘ˆ‘š›…‘†‘‡Ǥ

Ї•–—†›Šƒ••Š‘™–Šƒ––Ї˜ƒ”‹ƒ„އDz†ƒ‹Ž›†‘•‡‘ˆ‘š›…‘†‘‡dz„‡•–‡š’Žƒ‹‡†–Ї

˜ƒ”‹ƒ–‹‘‹„Ž‘‘†Ž‡˜‡Žǡ™Š‹Ž‡•‡šƒ†—•‡‘ˆ…‘Ǧ‡†‹…ƒ–‹‘•–Šƒ–ƒˆˆ‡…–•–Ї‡–ƒ„‘Ž‹•

‘ˆ‘š›…‘†‘‡˜‹ƒ͵Ͷ‡œ›‡•ǡŠƒ†–Š‡Žƒ”‰‡•–‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‹

–Ї„Ž‘‘†ƒ†–Ї”ƒ–‹‘‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡Ǥ•‡‘ˆ†”—‰•–Šƒ–‹Š‹„‹–ʹ͸

‡œ›‡•Šƒ†‘‡ˆˆ‡…–‘–Їއ˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡Ȁ‘š›…‘†‘‡”ƒ–‹‘‹

–Ї„Ž‘‘†Ǥ

‘”‡Žƒ–‹‘•Š‹’™ƒ•ˆ‘—†„‡–™‡‡Ž‡˜‡Ž‘ˆ‘š›…‘†‘‡‘”–Ї‡–ƒ„‘Ž‹–‡•‘”‘š›…‘†‘‡

ƒ†‘”‘š›‘”’Š‘‡‹–Ї„Ž‘‘†ƒ†’ƒ‹‹–‡•‹–›ǡƒ†•‹†‡‡ˆˆ‡…–•ȋƒ—•‡ƒǡ–‹”‡†‡••

(9)

ƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ȌǤ–‹ŽŽǡ–Ї—•‡‘ˆ–Ї͵Ͷ‹Š‹„‹–‘”ˆŽ—…‘ƒœ‘އ™ƒ•ƒ••‘…‹ƒ–‡†

™‹–ŠŽ‡••’ƒ‹ǡ™Š‹Ž‡ƒ‹…”‡ƒ•‡‘ˆ–Ї‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡ǡ’ƒ”ƒ†‘š‹…ƒŽŽ›ǡ™ƒ•

ƒ••‘…‹ƒ–‡†™‹–Š‹…”‡ƒ•‹‰’ƒ‹‹–Š‹•‰”‘—’‘ˆ’ƒ–‹‡–•ǤŠ‹•‹•†‹ˆˆ‹…—Ž––‘‡š’Žƒ‹ǡ„—–

™‡ƒŽ•‘‘„•‡”˜‡†–Šƒ–’ƒ–‹‡–•™Š‘Šƒ†Dz’‘‘”’ƒ‹…‘–”‘Žƒ†•‹†‡‡ˆˆ‡…–•dzǡ‰‡‡”ƒŽŽ›

Šƒ†–ЇЋ‰Š‡•–•‡”—…‘…‡–”ƒ–‹‘•‘ˆ„‘–Б𛅑†‘‡ƒ†‡–ƒ„‘Ž‹–‡•…‘’ƒ”‡†–‘

–Š‘•‡™Š‘™‡”‡Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†™‹–Š‘—–•‹†‡‡ˆˆ‡…–•dzǤŠ‹•™ƒ•‡•’‡…‹ƒŽŽ›–”—‡ˆ‘”–Ї

•‹†‡‡ˆˆ‡…–Dz–‹”‡†‡••dzǡ™Š‡”‡–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•™‹–ŠDz’ƒ‹ƒ†–‹”‡†‡••dz™ƒ•—…Š

Š‹‰Š‡”–Šƒ–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•„‡‹‰Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†‘––‹”‡†dzǤŠ‹••—‰‰‡•–•–Šƒ–

ƒ›’ƒ–‹‡–•ƒ”‡‘˜‡”†‘•‡†ǡƒ†–Šƒ––Ї•‡’ƒ–‹‡–••Š‘—Ž†Šƒ˜‡„‡‡‘ˆˆ‡”‡†ƒ

†‹ˆˆ‡”‡–†”—‰–Šƒ‘š›…‘†‘‡Ǥ

Š‹••–—†›ƒŽ•‘•Š‘™‡†–Šƒ––ЇCYP2D6‰‡‘–›’‡‹ˆŽ—‡…‡•–Їއ˜‡Ž‘ˆ‘š›‘”’Š‘‡

ƒ†‘”‘š›‘”’Š‘‡ǤŠ‹•ǡŠ‘™‡˜‡”ǡ†‘‡•‘–Šƒ˜‡ƒ›…‘•‡“—‡…‡ˆ‘”–Ї‡ˆˆ‡…–‘ˆ

–Ї‘š›…‘†‘‡–”‡ƒ–‡–„‡–™‡‡–Ї‰‡‘–›’‡•Ǥ

—„Œ‡…–‹˜‡‘—–…‘‡••—…Šƒ•’ƒ‹‹–‡•‹–›ǡ–‹”‡†‡••ǡƒ—•‡ƒƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ƒ›

ƒŽ•‘„‡…ƒ—•‡†„›–Ї…ƒ…‡”†‹•‡ƒ•‡‹–•‡ŽˆǤŠ‹•ƒ‡•–Ї”‡•—Ž–•…ŠƒŽŽ‡‰‹‰–‘

‹–‡”’”‡–Ǥ

…‘…Ž—•‹‘ǡ–Š‹••–—†›‹’Ž‹‡•–Šƒ–‡‹–Ї””‘—–‹‡•‡”—…‘…‡–”ƒ–‹‘

‡ƒ•—”‡‡–•‘”CYP2D6‰‡‘–›’‹‰ƒ”‡‹†‹…ƒ–‡††—”‹‰‘š›…‘†‘‡ƒ†‹‹•–”ƒ–‹‘Ǥ

—”‹‰…Š”‘‹…ƒ†‹‹•–”ƒ–‹‘ǡ–ЇƒƒŽ‰‡•‹…‡ˆˆ‡…–‹•ƒ‹Ž›‡†‹ƒ–‡†„›‘š›…‘†‘‡

‹–•‡ŽˆǤ‹”‡†‡••‹•ƒ’”‡˜ƒŽ‡–•›’–‘ƒ‘‰–Š‘•‡™Š‘Šƒ˜‡’‘‘”’ƒ‹…‘–”‘Žǡƒ†

–Š‹•ƒ›‹†‹…ƒ–‡ƒ‡‡†ˆ‘”ƒ•™‹–…Š–‘ƒ‘–Ї”‘’‹‘‹†Ǥƒ–‹‡–•™Š‘ƒ”‡‰‘‹‰–‘•–ƒ”–

‘Ǧ‘”†‹•…‘–‹—‡†”—‰•–Šƒ–ƒˆˆ‡…––Ї͵Ͷ‡œ›‡•›•–‡•Š‘—ކ„‡‘‹–‘”‡†

…Ž‘•‡Ž›Ǥ

ƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ȌǤ–‹ŽŽǡ–Ї—•‡‘ˆ–Ї͵Ͷ‹Š‹„‹–‘”ˆŽ—…‘ƒœ‘އ™ƒ•ƒ••‘…‹ƒ–‡†

™‹–ŠŽ‡••’ƒ‹ǡ™Š‹Ž‡ƒ‹…”‡ƒ•‡‘ˆ–Ї‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡ǡ’ƒ”ƒ†‘š‹…ƒŽŽ›ǡ™ƒ•

ƒ••‘…‹ƒ–‡†™‹–Š‹…”‡ƒ•‹‰’ƒ‹‹–Š‹•‰”‘—’‘ˆ’ƒ–‹‡–•ǤŠ‹•‹•†‹ˆˆ‹…—Ž––‘‡š’Žƒ‹ǡ„—–

™‡ƒŽ•‘‘„•‡”˜‡†–Šƒ–’ƒ–‹‡–•™Š‘Šƒ†Dz’‘‘”’ƒ‹…‘–”‘Žƒ†•‹†‡‡ˆˆ‡…–•dzǡ‰‡‡”ƒŽŽ›

Šƒ†–ЇЋ‰Š‡•–•‡”—…‘…‡–”ƒ–‹‘•‘ˆ„‘–Б𛅑†‘‡ƒ†‡–ƒ„‘Ž‹–‡•…‘’ƒ”‡†–‘

–Š‘•‡™Š‘™‡”‡Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†™‹–Š‘—–•‹†‡‡ˆˆ‡…–•dzǤŠ‹•™ƒ•‡•’‡…‹ƒŽŽ›–”—‡ˆ‘”–Ї

•‹†‡‡ˆˆ‡…–Dz–‹”‡†‡••dzǡ™Š‡”‡–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•™‹–ŠDz’ƒ‹ƒ†–‹”‡†‡••dz™ƒ•—…Š

Š‹‰Š‡”–Šƒ–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•„‡‹‰Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†‘––‹”‡†dzǤŠ‹••—‰‰‡•–•–Šƒ–

ƒ›’ƒ–‹‡–•ƒ”‡‘˜‡”†‘•‡†ǡƒ†–Šƒ––Ї•‡’ƒ–‹‡–••Š‘—Ž†Šƒ˜‡„‡‡‘ˆˆ‡”‡†ƒ

†‹ˆˆ‡”‡–†”—‰–Šƒ‘š›…‘†‘‡Ǥ

Š‹••–—†›ƒŽ•‘•Š‘™‡†–Šƒ––ЇCYP2D6‰‡‘–›’‡‹ˆŽ—‡…‡•–Їއ˜‡Ž‘ˆ‘š›‘”’Š‘‡

ƒ†‘”‘š›‘”’Š‘‡ǤŠ‹•ǡŠ‘™‡˜‡”ǡ†‘‡•‘–Šƒ˜‡ƒ›…‘•‡“—‡…‡ˆ‘”–Ї‡ˆˆ‡…–‘ˆ

–Ї‘š›…‘†‘‡–”‡ƒ–‡–„‡–™‡‡–Ї‰‡‘–›’‡•Ǥ

—„Œ‡…–‹˜‡‘—–…‘‡••—…Šƒ•’ƒ‹‹–‡•‹–›ǡ–‹”‡†‡••ǡƒ—•‡ƒƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ƒ›

ƒŽ•‘„‡…ƒ—•‡†„›–Ї…ƒ…‡”†‹•‡ƒ•‡‹–•‡ŽˆǤŠ‹•ƒ‡•–Ї”‡•—Ž–•…ŠƒŽŽ‡‰‹‰–‘

‹–‡”’”‡–Ǥ

…‘…Ž—•‹‘ǡ–Š‹••–—†›‹’Ž‹‡•–Šƒ–‡‹–Ї””‘—–‹‡•‡”—…‘…‡–”ƒ–‹‘

‡ƒ•—”‡‡–•‘”CYP2D6‰‡‘–›’‹‰ƒ”‡‹†‹…ƒ–‡††—”‹‰‘š›…‘†‘‡ƒ†‹‹•–”ƒ–‹‘Ǥ

—”‹‰…Š”‘‹…ƒ†‹‹•–”ƒ–‹‘ǡ–ЇƒƒŽ‰‡•‹…‡ˆˆ‡…–‹•ƒ‹Ž›‡†‹ƒ–‡†„›‘š›…‘†‘‡

‹–•‡ŽˆǤ‹”‡†‡••‹•ƒ’”‡˜ƒŽ‡–•›’–‘ƒ‘‰–Š‘•‡™Š‘Šƒ˜‡’‘‘”’ƒ‹…‘–”‘Žǡƒ†

–Š‹•ƒ›‹†‹…ƒ–‡ƒ‡‡†ˆ‘”ƒ•™‹–…Š–‘ƒ‘–Ї”‘’‹‘‹†Ǥƒ–‹‡–•™Š‘ƒ”‡‰‘‹‰–‘•–ƒ”–

‘Ǧ‘”†‹•…‘–‹—‡†”—‰•–Šƒ–ƒˆˆ‡…––Ї͵Ͷ‡œ›‡•›•–‡•Š‘—ކ„‡‘‹–‘”‡†

…Ž‘•‡Ž›Ǥ

ƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ȌǤ–‹ŽŽǡ–Ї—•‡‘ˆ–Ї͵Ͷ‹Š‹„‹–‘”ˆŽ—…‘ƒœ‘އ™ƒ•ƒ••‘…‹ƒ–‡†

™‹–ŠŽ‡••’ƒ‹ǡ™Š‹Ž‡ƒ‹…”‡ƒ•‡‘ˆ–Ї‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡ǡ’ƒ”ƒ†‘š‹…ƒŽŽ›ǡ™ƒ•

ƒ••‘…‹ƒ–‡†™‹–Š‹…”‡ƒ•‹‰’ƒ‹‹–Š‹•‰”‘—’‘ˆ’ƒ–‹‡–•ǤŠ‹•‹•†‹ˆˆ‹…—Ž––‘‡š’Žƒ‹ǡ„—–

™‡ƒŽ•‘‘„•‡”˜‡†–Šƒ–’ƒ–‹‡–•™Š‘Šƒ†Dz’‘‘”’ƒ‹…‘–”‘Žƒ†•‹†‡‡ˆˆ‡…–•dzǡ‰‡‡”ƒŽŽ›

Šƒ†–ЇЋ‰Š‡•–•‡”—…‘…‡–”ƒ–‹‘•‘ˆ„‘–Б𛅑†‘‡ƒ†‡–ƒ„‘Ž‹–‡•…‘’ƒ”‡†–‘

–Š‘•‡™Š‘™‡”‡Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†™‹–Š‘—–•‹†‡‡ˆˆ‡…–•dzǤŠ‹•™ƒ•‡•’‡…‹ƒŽŽ›–”—‡ˆ‘”–Ї

•‹†‡‡ˆˆ‡…–Dz–‹”‡†‡••dzǡ™Š‡”‡–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•™‹–ŠDz’ƒ‹ƒ†–‹”‡†‡••dz™ƒ•—…Š

Š‹‰Š‡”–Šƒ–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•„‡‹‰Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†‘––‹”‡†dzǤŠ‹••—‰‰‡•–•–Šƒ–

ƒ›’ƒ–‹‡–•ƒ”‡‘˜‡”†‘•‡†ǡƒ†–Šƒ––Ї•‡’ƒ–‹‡–••Š‘—Ž†Šƒ˜‡„‡‡‘ˆˆ‡”‡†ƒ

†‹ˆˆ‡”‡–†”—‰–Šƒ‘š›…‘†‘‡Ǥ

Š‹••–—†›ƒŽ•‘•Š‘™‡†–Šƒ––ЇCYP2D6‰‡‘–›’‡‹ˆŽ—‡…‡•–Їއ˜‡Ž‘ˆ‘š›‘”’Š‘‡

ƒ†‘”‘š›‘”’Š‘‡ǤŠ‹•ǡŠ‘™‡˜‡”ǡ†‘‡•‘–Šƒ˜‡ƒ›…‘•‡“—‡…‡ˆ‘”–Ї‡ˆˆ‡…–‘ˆ

–Ї‘š›…‘†‘‡–”‡ƒ–‡–„‡–™‡‡–Ї‰‡‘–›’‡•Ǥ

—„Œ‡…–‹˜‡‘—–…‘‡••—…Šƒ•’ƒ‹‹–‡•‹–›ǡ–‹”‡†‡••ǡƒ—•‡ƒƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ƒ›

ƒŽ•‘„‡…ƒ—•‡†„›–Ї…ƒ…‡”†‹•‡ƒ•‡‹–•‡ŽˆǤŠ‹•ƒ‡•–Ї”‡•—Ž–•…ŠƒŽŽ‡‰‹‰–‘

‹–‡”’”‡–Ǥ

…‘…Ž—•‹‘ǡ–Š‹••–—†›‹’Ž‹‡•–Šƒ–‡‹–Ї””‘—–‹‡•‡”—…‘…‡–”ƒ–‹‘

‡ƒ•—”‡‡–•‘”CYP2D6‰‡‘–›’‹‰ƒ”‡‹†‹…ƒ–‡††—”‹‰‘š›…‘†‘‡ƒ†‹‹•–”ƒ–‹‘Ǥ

—”‹‰…Š”‘‹…ƒ†‹‹•–”ƒ–‹‘ǡ–ЇƒƒŽ‰‡•‹…‡ˆˆ‡…–‹•ƒ‹Ž›‡†‹ƒ–‡†„›‘š›…‘†‘‡

‹–•‡ŽˆǤ‹”‡†‡••‹•ƒ’”‡˜ƒŽ‡–•›’–‘ƒ‘‰–Š‘•‡™Š‘Šƒ˜‡’‘‘”’ƒ‹…‘–”‘Žǡƒ†

–Š‹•ƒ›‹†‹…ƒ–‡ƒ‡‡†ˆ‘”ƒ•™‹–…Š–‘ƒ‘–Ї”‘’‹‘‹†Ǥƒ–‹‡–•™Š‘ƒ”‡‰‘‹‰–‘•–ƒ”–

‘Ǧ‘”†‹•…‘–‹—‡†”—‰•–Šƒ–ƒˆˆ‡…––Ї͵Ͷ‡œ›‡•›•–‡•Š‘—ކ„‡‘‹–‘”‡†

…Ž‘•‡Ž›Ǥ

ƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ȌǤ–‹ŽŽǡ–Ї—•‡‘ˆ–Ї͵Ͷ‹Š‹„‹–‘”ˆŽ—…‘ƒœ‘އ™ƒ•ƒ••‘…‹ƒ–‡†

™‹–ŠŽ‡••’ƒ‹ǡ™Š‹Ž‡ƒ‹…”‡ƒ•‡‘ˆ–Ї‡–ƒ„‘Ž‹–‡‘š›‘”’Š‘‡ǡ’ƒ”ƒ†‘š‹…ƒŽŽ›ǡ™ƒ•

ƒ••‘…‹ƒ–‡†™‹–Š‹…”‡ƒ•‹‰’ƒ‹‹–Š‹•‰”‘—’‘ˆ’ƒ–‹‡–•ǤŠ‹•‹•†‹ˆˆ‹…—Ž––‘‡š’Žƒ‹ǡ„—–

™‡ƒŽ•‘‘„•‡”˜‡†–Šƒ–’ƒ–‹‡–•™Š‘Šƒ†Dz’‘‘”’ƒ‹…‘–”‘Žƒ†•‹†‡‡ˆˆ‡…–•dzǡ‰‡‡”ƒŽŽ›

Šƒ†–ЇЋ‰Š‡•–•‡”—…‘…‡–”ƒ–‹‘•‘ˆ„‘–Б𛅑†‘‡ƒ†‡–ƒ„‘Ž‹–‡•…‘’ƒ”‡†–‘

–Š‘•‡™Š‘™‡”‡Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†™‹–Š‘—–•‹†‡‡ˆˆ‡…–•dzǤŠ‹•™ƒ•‡•’‡…‹ƒŽŽ›–”—‡ˆ‘”–Ї

•‹†‡‡ˆˆ‡…–Dz–‹”‡†‡••dzǡ™Š‡”‡–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•™‹–ŠDz’ƒ‹ƒ†–‹”‡†‡••dz™ƒ•—…Š

Š‹‰Š‡”–Šƒ–Ї’‘”–‹‘‘ˆ’ƒ–‹‡–•„‡‹‰Dz’ƒ‹”‡Ž‹‡˜‡†ƒ†‘––‹”‡†dzǤŠ‹••—‰‰‡•–•–Šƒ–

ƒ›’ƒ–‹‡–•ƒ”‡‘˜‡”†‘•‡†ǡƒ†–Šƒ––Ї•‡’ƒ–‹‡–••Š‘—Ž†Šƒ˜‡„‡‡‘ˆˆ‡”‡†ƒ

†‹ˆˆ‡”‡–†”—‰–Šƒ‘š›…‘†‘‡Ǥ

Š‹••–—†›ƒŽ•‘•Š‘™‡†–Šƒ––ЇCYP2D6‰‡‘–›’‡‹ˆŽ—‡…‡•–Їއ˜‡Ž‘ˆ‘š›‘”’Š‘‡

ƒ†‘”‘š›‘”’Š‘‡ǤŠ‹•ǡŠ‘™‡˜‡”ǡ†‘‡•‘–Šƒ˜‡ƒ›…‘•‡“—‡…‡ˆ‘”–Ї‡ˆˆ‡…–‘ˆ

–Ї‘š›…‘†‘‡–”‡ƒ–‡–„‡–™‡‡–Ї‰‡‘–›’‡•Ǥ

—„Œ‡…–‹˜‡‘—–…‘‡••—…Šƒ•’ƒ‹‹–‡•‹–›ǡ–‹”‡†‡••ǡƒ—•‡ƒƒ†…‘‰‹–‹˜‡ˆ—…–‹‘ƒ›

ƒŽ•‘„‡…ƒ—•‡†„›–Ї…ƒ…‡”†‹•‡ƒ•‡‹–•‡ŽˆǤŠ‹•ƒ‡•–Ї”‡•—Ž–•…ŠƒŽŽ‡‰‹‰–‘

‹–‡”’”‡–Ǥ

…‘…Ž—•‹‘ǡ–Š‹••–—†›‹’Ž‹‡•–Šƒ–‡‹–Ї””‘—–‹‡•‡”—…‘…‡–”ƒ–‹‘

‡ƒ•—”‡‡–•‘”CYP2D6‰‡‘–›’‹‰ƒ”‡‹†‹…ƒ–‡††—”‹‰‘š›…‘†‘‡ƒ†‹‹•–”ƒ–‹‘Ǥ

—”‹‰…Š”‘‹…ƒ†‹‹•–”ƒ–‹‘ǡ–ЇƒƒŽ‰‡•‹…‡ˆˆ‡…–‹•ƒ‹Ž›‡†‹ƒ–‡†„›‘š›…‘†‘‡

‹–•‡ŽˆǤ‹”‡†‡••‹•ƒ’”‡˜ƒŽ‡–•›’–‘ƒ‘‰–Š‘•‡™Š‘Šƒ˜‡’‘‘”’ƒ‹…‘–”‘Žǡƒ†

–Š‹•ƒ›‹†‹…ƒ–‡ƒ‡‡†ˆ‘”ƒ•™‹–…Š–‘ƒ‘–Ї”‘’‹‘‹†Ǥƒ–‹‡–•™Š‘ƒ”‡‰‘‹‰–‘•–ƒ”–

‘Ǧ‘”†‹•…‘–‹—‡†”—‰•–Šƒ–ƒˆˆ‡…––Ї͵Ͷ‡œ›‡•›•–‡•Š‘—ކ„‡‘‹–‘”‡†

…Ž‘•‡Ž›Ǥ

(10)

TableofContents

Acknowledgements...1

Listofpapers...5

Abbreviations...6

Glossary...7

Introduction...11

Cancerpatients...11

Pain...12

CancerPain...12

WHO’sthreeͲstep"ladder"forcancerpainrelief...13

Opioidmechanismofaction...15

BloodͲBrainBarrier...16

InterͲindividualvariabilityinresponsetoanopioid...17

Adverseeffects...17

Oxycodoneversusmorphine...18

Oxycodone...19

ControlledͲrelease(CR)versusimmediateͲrelease(IR)oxycodone...20

Clinicalindications...21

Metabolismandpharmacokinetics...21

TheCYP3A4metabolicpathway...24

TheCYP2D6metabolicpathway...24

CYP2D6pharmacogenetics...24

TheCYP2D6Ͳgenotypeinfluenceonthepharmacokineticsandpharmacodynamicsofoxycodone.25 Assessmentofsymptoms...26

Rationaleforthisthesis...27

Studyobjectives...31

Materialandmethods...33

Patientcohort...33

TheEuropeanPharmacogeneticOpioidStudy,EPOS...33

SerumconcentrationanalysesbyliquidchromatographyͲtandemmassspectrometry...36

DeterminationoftheCYP2D6Ͳgenotypes...38

Briefpaininventory(BPI)...40

TableofContents

Acknowledgements...1

Listofpapers...5

Abbreviations...6

Glossary...7

Introduction...11

Cancerpatients...11

Pain...12

CancerPain...12

WHO’sthreeͲstep"ladder"forcancerpainrelief...13

Opioidmechanismofaction...15

BloodͲBrainBarrier...16

InterͲindividualvariabilityinresponsetoanopioid...17

Adverseeffects...17

Oxycodoneversusmorphine...18

Oxycodone...19

ControlledͲrelease(CR)versusimmediateͲrelease(IR)oxycodone...20

Clinicalindications...21

Metabolismandpharmacokinetics...21

TheCYP3A4metabolicpathway...24

TheCYP2D6metabolicpathway...24

CYP2D6pharmacogenetics...24

TheCYP2D6Ͳgenotypeinfluenceonthepharmacokineticsandpharmacodynamicsofoxycodone.25 Assessmentofsymptoms...26

Rationaleforthisthesis...27

Studyobjectives...31

Materialandmethods...33

Patientcohort...33

TheEuropeanPharmacogeneticOpioidStudy,EPOS...33

SerumconcentrationanalysesbyliquidchromatographyͲtandemmassspectrometry...36

DeterminationoftheCYP2D6Ͳgenotypes...38

Briefpaininventory(BPI)...40

TableofContents

Acknowledgements...1

Listofpapers...5

Abbreviations...6

Glossary...7

Introduction...11

Cancerpatients...11

Pain...12

CancerPain...12

WHO’sthreeͲstep"ladder"forcancerpainrelief...13

Opioidmechanismofaction...15

BloodͲBrainBarrier...16

InterͲindividualvariabilityinresponsetoanopioid...17

Adverseeffects...17

Oxycodoneversusmorphine...18

Oxycodone...19

ControlledͲrelease(CR)versusimmediateͲrelease(IR)oxycodone...20

Clinicalindications...21

Metabolismandpharmacokinetics...21

TheCYP3A4metabolicpathway...24

TheCYP2D6metabolicpathway...24

CYP2D6pharmacogenetics...24

TheCYP2D6Ͳgenotypeinfluenceonthepharmacokineticsandpharmacodynamicsofoxycodone.25 Assessmentofsymptoms...26

Rationaleforthisthesis...27

Studyobjectives...31

Materialandmethods...33

Patientcohort...33

TheEuropeanPharmacogeneticOpioidStudy,EPOS...33

SerumconcentrationanalysesbyliquidchromatographyͲtandemmassspectrometry...36

DeterminationoftheCYP2D6Ͳgenotypes...38

Briefpaininventory(BPI)...40

TableofContents

Acknowledgements...1

Listofpapers...5

Abbreviations...6

Glossary...7

Introduction...11

Cancerpatients...11

Pain...12

CancerPain...12

WHO’sthreeͲstep"ladder"forcancerpainrelief...13

Opioidmechanismofaction...15

BloodͲBrainBarrier...16

InterͲindividualvariabilityinresponsetoanopioid...17

Adverseeffects...17

Oxycodoneversusmorphine...18

Oxycodone...19

ControlledͲrelease(CR)versusimmediateͲrelease(IR)oxycodone...20

Clinicalindications...21

Metabolismandpharmacokinetics...21

TheCYP3A4metabolicpathway...24

TheCYP2D6metabolicpathway...24

CYP2D6pharmacogenetics...24

TheCYP2D6Ͳgenotypeinfluenceonthepharmacokineticsandpharmacodynamicsofoxycodone.25 Assessmentofsymptoms...26

Rationaleforthisthesis...27

Studyobjectives...31

Materialandmethods...33

Patientcohort...33

TheEuropeanPharmacogeneticOpioidStudy,EPOS...33

SerumconcentrationanalysesbyliquidchromatographyͲtandemmassspectrometry...36

DeterminationoftheCYP2D6Ͳgenotypes...38

Briefpaininventory(BPI)...40

Referanser

RELATERTE DOKUMENTER

The EPCRC-CSA study included cancer patients whose pain was evaluated by several self-reported assessment methods [22], provid- ing an opportunity to address the research question:

Our study showed that pain was highly prevalent during the first year after surgery for lung cancer, and subgroups of patients could be identified based on different

Next, we present cryptographic mechanisms that we have found to be typically implemented on common commercial unmanned aerial vehicles, and how they relate to the vulnerabilities

Based on the above-mentioned tensions, a recommendation for further research is to examine whether young people who have participated in the TP influence their parents and peers in

Based on the results from Soeters’ (1997) study of cross-cultural differences in a military sample, the current study asked whether members of the military really are different

This qualitative systematic review of the clinical methodology used in randomised, controlled trials of oral opioids (morphine, hydromorphone, oxycodone) for cancer pain underlines

Ketamine is the most studied NMDA receptor antagonist in clinical pain trials, and is commonly used for the treatment of refractory cancer pain, and as an opioid-sparing drug in

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy nave patients and patients pretreated with fluorouracil-based chemotherapy. Pitot HC,